# EDGAR Filing Document

**Accession Number:** 0000840715
**File Stem:** 0001753926-26-000600
**Filing Date:** 2026-3
**Character Count:** 212900
**Document Hash:** 989ee0a8b253c6b876f76af85f7de416
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-26-000600.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0001753926-26-000600

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 95

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CLEARONE INC
- **CENTRAL INDEX KEY:** 0000840715
- **STANDARD INDUSTRIAL CLASSIFICATION:** TELEPHONE & TELEGRAPH APPARATUS [3661]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 870398877
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33660
- **FILM NUMBER:** 26822534

**BUSINESS ADDRESS:**
- **STREET 1:** 5225 WILEY POST WAY
- **STREET 2:** SUITE 500
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84116
- **BUSINESS PHONE:** 8019757200

**MAIL ADDRESS:**
- **STREET 1:** 5225 WILEY POST WAY
- **STREET 2:** SUITE 500
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84116

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CLEARONE COMMUNICATIONS INC
- **DATE OF NAME CHANGE:** 20020204

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GENTNER COMMUNICATIONS CORP
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GENTNER ELECTRONICS CORP
- **DATE OF NAME CHANGE:** 19910808

?xml version='1.0' encoding='ASCII'? clro-20251231.htm

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

WASHINGTON, D.C. 20549

**Form 10-K**

(Mark One)

---

| | |
|:---|:---|
| ☒  | **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**  |
|  | For the fiscal year ended December 31, 2025  |

---

---

| | |
|:---|:---|
| ☐  | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**  |
|  | For the transition period from _________ to _________  |

---

Commission file number <u>001-33660</u>

**CLEARONE, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **87-0398877**  |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. employer identification number)  |

---

---

| | |
|:---|:---|
| **5225 Wiley Post Way, Suite 500, Salt Lake City, Utah**  | **84116**  |
| (Address of principal executive offices)  | (Zip Code)  |

---

Registrant's telephone number, including area code: <u>(801) 975-7200</u>

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class**  | &nbsp;&nbsp;&nbsp;&nbsp;**Trading Symbol(s)** | **Name on each exchange on which registered**  |
| Common Stock, $0.001 par value  | &nbsp;&nbsp;&nbsp;&nbsp;CLRO | The Nasdaq Capital Market  |

---

Securities registered pursuant to Section 12(g) of the Act: None

________________

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐Yes ☒No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐Yes ☒No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒Yes ☐No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒Yes ☐No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | |
|:---|:---|
| Larger Accelerated Filer ☐ | Accelerated Filer ☐  |
| Non-Accelerated Filer ☒  | Smaller Reporting Company ☒  |
|  | Emerging Growth Company ☐  |

---

------

[**Table of Contents**](#TOC)

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell Company (as defined in Rule 12b-2 of the Act). ☐Yes ☒No

The aggregate market value of the shares of voting common stock held by non-affiliates was approximately $5.1 million at June 30, 2025**,** (the Company's most recently completed second fiscal quarter), based on the $5.7500 closing price for the Company's common stock on the Nasdaq Capital Market on such date. For purposes of this computation, all officers, directors, and 10% beneficial owners of the registrant are deemed to be affiliates. Such determination should not be deemed to be an admission that such officers, directors, or 10% beneficial owners are, in fact, affiliates of the registrant.

The number of shares of ClearOne common stock outstanding as of March 31, 2026 was 2,675,412.

**Documents Incorporated by Reference:** None

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

**Annual Report on Form 10-K For the year ended December 31, 2025**

**Table of Contents**

---

| | | |
|:---|:---|:---|
|  |  | Page |
|  | [PART I](#BA_CFOVR5EM8000000000000000000000) | 2 |
| Item 1. | [Business](#BB_SWO1LCYT7400000000000000000000) | 2 |
| Item 1A. | [Risk Factors](#BRF_KNJT6EYARK00000000000000000000) | 3 |
| Item 1B. | [Unresolved Staff Comments](#BAAA_B36RTR4S7400000000000000000000) | 8 |
| Item 1C. | [Cybersecurity](#Baa_292202511937831) | 9 |
| Item 2. | [Properties](#BSB-01_1622026202022996) | 9 |
| Item 3. | [Legal Proceedings](#BF_6R0M0IZUU800000000000000000000) | 9 |
| Item 4. | [Mine Safety Disclosures](#BG_ODMGIDN1RK00000000000000000000) | 9 |
|  | [PART II](#BH_Q9L7TKCHZ400000000000000000000) | 10 |
| Item 5. | [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#BI_LPR1G1JEZ400000000000000000000) | 10 |
| Item 6. | [Reserved](#BJ_E6DCU6PUGG00000000000000000000) | 10 |
| Item 7. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#BK_SAPU2DDP7K00000000000000000000) | 10 |
| Item 7A. | [Quantitative and Qualitative Disclosures about Market Risk](#BL_KEF9VQT3PC00000000000000000000) | 14 |
| Item 8. | [Financial Statements and Supplementary Data](#BIt8_1BI6QLLEZ400000000000000000000) | 14 |
| Item 9. | [Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#BN_656CSYXQWG00000000000000000000) | 14 |
| Item 9A. | [Controls and Procedures](#BO_XFEHFTGHAO00000000000000000000) | 14 |
| Item 9B. | [Other Information](#BP_VPZ8QCDNYO00000000000000000000) | 15 |
| Item 9C. | [Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#BB9C_E0IXHJULOW00000000000000000000) | 15 |
|  | [PART III](#BQ_IUEDPQACSW00000000000000000000) | 16 |
| Item 10. | [Directors, Executive Officers and Corporate Governance](#BR_3C14CBQWS000000000000000000000) | 16 |
| Item 11. | [Executive Compensation](#BS_9H0211KAKW00000000000000000000) | 18 |
| Item 12. | [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#BT_7T31KB3JZ400000000000000000000) | 19 |
| Item 13. | [Certain Relationships and Related Transactions, and Director Independence](#BU_NXPJ5NC69S00000000000000000000) | 21 |
| Item 14. | [Principal Accounting Fees and Services](#BV_5JJDQA3YDC00000000000000000000) | 22 |
|  | [PART IV](#BW_NL3ULECWZK00000000000000000000) | 23 |
| Item 15. | [Exhibits, Financial Statement Schedules](#BX_02V3936Q3K00000000000000000000) | 23 |
| Item 16. | [Form 10-K Summary](#BY_4Q3RWEAEAO00000000000000000000) | 23 |

---

------

[**Table of Contents**](#TOC)

**SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS**

This report contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements reflect our views with respect to future events based upon information available to us at this time. These forward-looking statements are subject to uncertainties and other factors that could cause actual results to differ materially from these statements. Forward-looking statements are typically identified by the use of the words "believe," "may," "could," "will," "should," "expect," "anticipate," "estimate," "project," "propose," "plan," "intend," and similar words and expressions. Examples of forward-looking statements are statements that describe the company's review of strategic alternatives, proposed development, manufacturing, and sale of our products; statements that describe expectations regarding pricing trends, the markets for our products, our anticipated capital expenditures, our cost reduction and operational restructuring initiatives, and future impact of regulatory developments; statements with regard to the nature and extent of competition we may face in the future; statements with respect to the anticipated sources of and need for future financing; and statements with respect to future strategic plans, goals, and objectives and forecasts of future growth and value. Forward-looking statements are contained in this report under "Business" included in Item 1 of Part I, and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in Item 7 of Part II of this Annual Report on Form 10-K. The forward-looking statements are based on present circumstances and on our predictions respecting events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Actual events or results may differ materially from those discussed in the forward-looking statements as a result of various factors, including the risk factors discussed in this report under the caption "Item 1A Risk Factors." These cautionary statements are intended to be applicable to all related forward-looking statements wherever they appear in this report. The cautionary statements contained or referred to in this report should also be considered in connection with any subsequent written or oral forward-looking statements that may be issued by us or persons acting on our behalf. Any forward-looking statements are made only as of the date of this report and we assume no obligation to update forward-looking statements to reflect subsequent events or circumstances.

------

[**Table of Contents**](#TOC)

[**PART I**](#TOC)

References in this Annual Report on Form 10-K to "ClearOne," "we," "us," "CLRO" or "the Company" refer to ClearOne, Inc., a Delaware corporation, and, unless the context otherwise requires or is otherwise expressly stated, its subsidiaries.

[**ITEM 1. BUSINESS**](#)

**GENERAL** 

ClearOne, Inc. (the "Company," "we," "us" or "our"), a Delaware corporation, was previously engaged in the design, development, and marketing of professional audio conferencing, microphone, and video collaboration solutions.

All share and per-share amounts presented in this report (current and historical) have been adjusted to reflect the 15-for-1 reverse stock split effected in June 2025.

**October 2025 Asset Sale** 

On October 24, 2025, the Company completed the sale of certain intellectual property, product inventory, and non-exclusive rights to customer data to Biamp Systems, LLC ("Biamp") for gross cash consideration of $3.0 million (the "Asset Sale") pursuant to an Asset Purchase Agreement dated the same date. Biamp did not assume any warranty or technical support obligations. The Company retained its books and records, all equity interests in subsidiaries, certain minor assets (including a limited amount of inventory held solely to service warranties), and all public-company assets and obligations. See Note 2 to the Consolidated Financial Statements and the Company's Current Report on Form 8-K filed October 30, 2025 for additional information regarding the Asset Sale.

**Post-Asset-Sale Operations**

Following the Asset Sale, the Company no longer manufactures or sells products and maintains a limited inventory and provides customer support services to satisfy warranty claims. Its continuing activities consist solely of (i) fulfilling warranty and technical support obligations on legacy products in accordance with published policies, (ii) managing and liquidating remaining assets of the Company's legacy operating business, (iii) evaluating potential strategic transactions; (iv) collecting accounts receivable and recovering prepaid assets, (v) satisfying outstanding liabilities, and (vi) maintaining public-company compliance. These activities are transitional in nature and are not expected to generate material revenue.

**Strategy and Strategic Alternatives**

The Company is actively evaluating strategic alternatives intended to enhance stockholder value. These alternatives may include without limitation one or more special transactions, an investment in, or an acquisition of a private operating company, additional asset sales, or other actions that maximize value for stockholders. The closing of the Asset Sale on October 24, 2025 triggered the mandatory redemption of all outstanding shares of the Company's Class A Redeemable Preferred Stock. The Company currently estimates the final redemption amount will be approximately $50 after permitted expenses and net asset recoveries. There can be no assurance that any strategic transaction will be completed on favorable terms or at all.

**Significant Ownership Changes**

On November 24, 2025, Edward D. Bagley sold 700,000 shares of common stock to First Finance Ltd. As of December 31, 2025, First Finance Ltd. beneficially owned approximately 53.8% of our outstanding common stock. Any material changes in ownership after December 31, 2025 are disclosed as subsequent events where required.

**Company Information**

Our website address is www.clearone.com. We make our annual, quarterly, and current reports available free of charge on the "Investor Relations" section of our website as soon as reasonably practicable after filing with the SEC. The SEC maintains a website at www.sec.gov that contains reports, proxy statements, and other information regarding issuers that file electronically.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For a discussion of certain risks applicable to our business, results of operations, financial position, and liquidity, see the risk factors described in "Item 1A, Risk Factors" below.

------

[**Table of Contents**](#TOC)

[**ITEM 1A. RISK FACTORS**](#)

*Investors should carefully consider the risks described below. The risks described below are not the only ones we face and there are risks that we are not presently aware of or that we currently believe are immaterial that may also impair our business operations. Any of these risks could harm our business. The trading price of our common stock could decline significantly due to any of these risks, and investors may lose all or part of their investment. In assessing these risks, investors should also refer to the other information contained or incorporated by reference in this annual report on Form 10-K, including our consolidated financial statements and related notes.*

**Risks Relating to Our Business**

 *We may not be successful in completing a strategic transaction within a reasonable timeframe, on attractive terms or at all. If we are unable to complete a strategic transaction, we may not be able to continue as a going concern.*

In November 2024, we announced that our board of directors had formed a Special Transaction Committee (the "Special Transaction Committee") to conduct a comprehensive review of strategic alternatives focused on maximizing stockholder value, including, but not limited to, equity or debt financing alternatives, merger and acquisition transactions, divestiture of assets, licensing opportunities, joint ventures, collaborations or other commercial arrangements with other companies, or other special transactions (each, a "Strategic Transaction"). Following the disposition of certain operating assets in October 2025 and the resulting transition to a reduced, transitional operating posture, our ability to enhance stockholder value and improve our liquidity position is highly dependent on the successful evaluation and execution of one or more Strategic Transactions.

We may be unable to complete a Strategic Transaction within a reasonable timeframe, on attractive terms, or at all. Market conditions, including the historical volatility of our common stock, may limit our ability to raise capital on favorable terms, or at all, and any public or private offering of debt or equity securities may be significantly dilutive to existing stockholders. There is no set timetable for the overall process, as anticipated timelines for different strategic alternatives may vary, and there can be no assurance that this process will result in us pursuing a transaction or that any transaction, if pursued, will be completed on attractive terms or at all. If we are unable to complete a Strategic Transaction or otherwise obtain additional capital, our ability to continue operations and satisfy our obligations could be materially adversely affected. A Strategic Transaction, if completed, may substantially change the nature of our business, capital structure, and stockholder rights.

*We will require additional financing to fund our operations and obligations, which may not be available to us on acceptable terms or at all, and our auditor has expressed substantial doubt about our ability to continue as a going concern.*

As of December 31, 2025, we had approximately $0.74 million of cash and cash equivalents and restricted cash. Following the October 2025 disposition of certain operating assets and the resulting reduction in revenue-generating activities, our continuing activities primarily consist, among other things, of maintaining public company compliance and fulfilling ongoing obligations, including warranty servicing and technical support related to products sold prior to the asset sale, managing remaining assets and liabilities, and evaluating and pursuing strategic alternatives. These activities are not expected to generate revenue at levels sufficient to fund ongoing operating costs. As a result, we will require additional financing and/or the completion of one or more Strategic Transactions to fund ongoing operating costs, professional fees, compliance costs, and other obligations as they become due.

The financial statements included with this annual report on Form 10-K have been prepared on a going concern basis. We have incurred significant losses and experienced negative cash flows, and substantial doubt exists about our ability to continue as a going concern. We may not be able to obtain the necessary financing, complete a Strategic Transaction, or otherwise improve our liquidity position on acceptable terms or at all. The outcome of these matters cannot be predicted with any certainty at this time. Our financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should we be unable to continue as a going concern.

------

[**Table of Contents**](#TOC)

*Following the disposition of certain operating assets, we have limited continuing activities that are not expected to generate revenue at levels sufficient to fund ongoing operating costs.*

Our continuing activities are not expected to generate material revenue at levels sufficient to fund ongoing operating costs. As a result, our ability to sustain operations depends on available cash resources, access to additional capital, and/or the successful completion of one or more Strategic Transactions. If we are unable to obtain additional capital or complete a Strategic Transaction on acceptable terms or at all, we may be required to significantly curtail operations or pursue an orderly wind-down of the Company, which could result in reduced recoveries for stockholders.

*We are at risk for being delisted from the Nasdaq Capital Market for non-compliance with Nasdaq's continued listing standards.*

Although our common stock is currently listed on the Nasdaq Capital Market, as of December 31, 2025, we are not in compliance with any of the quantitative continued listing standards under Nasdaq Marketplace Rule 5550, and we anticipate receiving a notice of non-compliance from Nasdaq.

If we are unable to regain compliance with Nasdaq's continued listing standards within any applicable cure period, our common stock could be subject to delisting from the Nasdaq Capital Market.

Delisting of our common stock from Nasdaq could significantly reduce the liquidity and market price of our common stock and could make it more difficult for us to access the capital markets on acceptable terms, if at all. Even after we receive a notice of non-compliance, we may not be able to regain compliance within the timeframe provided by Nasdaq. Alternative markets, such as the over-the-counter markets, generally have less liquidity and visibility than Nasdaq, and trading on such markets could adversely affect the ability of stockholders to sell their shares at a desired price.

*We remain responsible for warranty and other obligations associated with products sold prior to the October 2025 asset disposition.* 

Although we completed the disposition of certain operating assets in October 2025, we continue to fulfill warranty servicing and technical support obligations related to products sold prior to the transaction. The ultimate cost of satisfying these obligations is subject to uncertainty, and actual costs may exceed current estimates or previously recorded reserves. Unexpected increases in warranty claims, service costs, parts costs, or related liabilities could materially adversely affect our financial condition and liquidity.

In addition, we may remain subject to claims, disputes, or other liabilities arising from our legacy operations. The resolution of such matters may require significant cash expenditures or result in additional liabilities.

------

[**Table of Contents**](#TOC)

*Our reduced workforce may impair our ability to maintain effective internal controls and public company compliance.*

Following the October 2025 asset disposition, we operate with a significantly reduced workforce. Maintaining effective internal control over financial reporting and complying with public company reporting obligations requires significant management attention and resources. If we are unable to maintain effective controls or comply with applicable reporting requirements, we could be subject to regulatory scrutiny.

*Cybersecurity incidents or other information technology disruptions could adversely affect our operations and expose us to liability.*

Although our operations have been significantly reduced following the October 2025 asset disposition, we continue to maintain information systems that support our public company reporting, financial management, warranty servicing activities, and administrative functions. We also retain certain sensitive information, including employee data and historical business information.

Despite security measures, our information systems may be vulnerable to cybersecurity incidents, including unauthorized access, ransomware attacks, phishing attempts, or other disruptions caused by third parties or internal actors. Because we operate with a limited workforce, our ability to detect, respond to, and remediate cybersecurity incidents may be constrained. Any significant breach could result in regulatory scrutiny, legal claims, reputational harm, increased compliance costs, or operational disruption.

*Global economic conditions and capital market volatility may adversely affect our ability to obtain financing or complete a strategic transaction.*

Global economic conditions, including inflation, rising interest rates, geopolitical conflicts, financial market volatility and tightening credit markets, may adversely affect our ability to raise capital or complete a Strategic Transaction. Volatility in equity markets may negatively impact the trading price of our common stock and limit our ability to issue equity or equity-linked securities on favorable terms, or at all.

Adverse economic conditions may also reduce investor appetite for special situation or transitional companies, which could impair our ability to attract potential transaction partners or financing sources. If we are unable to access capital markets or complete a Strategic Transaction due to adverse economic conditions, our financial condition and ability to continue operations could be materially adversely affected.

*Geopolitical events and international conflicts may increase financial market volatility and adversely affect our liquidity and strategic alternatives.*

Ongoing geopolitical conflicts, including the war in Ukraine and other international tensions, have resulted in increased volatility in global financial markets. Sanctions, trade restrictions, supply chain disruptions and broader economic instability may continue to affect capital markets and investor confidence. Although we no longer conduct significant operating activities, prolonged instability in global markets could negatively impact our ability to raise capital, regain compliance with listing requirements, or complete a Strategic Transaction.

Our limited international administrative activities may be subject to risks associated with operating in foreign jurisdictions.

We maintain limited personnel and administrative activities in certain foreign jurisdictions, including India. Although our continuing activities are significantly reduced, we remain subject to local labor laws, tax regulations, regulatory requirements, and legal systems in these jurisdictions. Changes in political, economic, regulatory, or security conditions in these countries could increase compliance costs, result in disputes, or otherwise adversely affect our ability to manage remaining obligations and corporate matters efficiently.

Additionally, differences in legal systems and enforcement mechanisms may increase the difficulty or cost of resolving disputes or collecting assets in foreign jurisdictions.

------

[**Table of Contents**](#TOC)

*We are highly dependent on a small number of executive officers and personnel.*

Following the October 2025 disposition of certain operating assets, we operate with a significantly reduced workforce and rely on a limited number of executive officers and key personnel to manage our public company compliance obligations, oversee warranty servicing activities, manage remaining assets and liabilities, and evaluate potential Strategic Transactions.

The loss of the services of our chief executive officer, chief financial officer, or other key personnel could materially impair our ability to meet reporting obligations, maintain effective internal controls, manage liquidity, or complete a Strategic Transaction. We do not maintain key person life insurance on our executive officers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Because of our limited personnel structure, the unexpected departure or unavailability of key personnel could have a disproportionately adverse impact on our financial condition and ability to continue operations.

**Risks Relating to Share Ownership**

*Our largest stockholder has significant influence over corporate matters.*

Subsequent to year end, on March 11, 2026, we closed a private placement with the Company's largest stockholder for aggregate gross proceeds of $1.75 million through the issuance of 437,500 shares of common stock and a warrant to purchase up to an additional 437,500 shares. The agreement also grants the stockholder consent rights over certain new debt and material transactions.

The agreement also imposes customary restrictions, including limitations on incurring new debt above certain thresholds and entering into material transactions without the purchaser's consent. If we are unable to satisfy the reincorporation condition or if the purchaser exercises its rights under the restrictions, our ability to pursue strategic alternatives, raise additional capital, or manage liquidity could be materially constrained. In addition, because the financing was provided by our largest stockholder, matters relating to the shares, warrant, or any future modifications could involve potential conflicts of interest and may influence or control the terms and structure of any strategic transaction.

As of March 16, 2026, our largest stockholder beneficially owned approximately 61.3% of our outstanding common stock. As a result, this stockholder has the ability to control the outcome of matters submitted to stockholders for approval, including the election of directors, approval of mergers or business combinations, and amendments to our organizational documents. This concentration of ownership and the additional contractual rights may discourage, delay, or prevent a change in control transaction that other stockholders may consider favorable and may cause decisions to be made that differ from the interests of other stockholders.

------

[**Table of Contents**](#TOC)

*Outstanding warrants and redeemable preferred stock may adversely affect the market price of our common stock and complicate strategic transactions.* 

We have outstanding warrants that are exercisable into shares of common stock. The exercise of these warrants would result in dilution to existing common stockholders. In addition, we have outstanding shares of Class A Redeemable Preferred Stock. The closing of the Asset Sale on October 24, 2025 triggered the mandatory redemption of the Class A Redeemable Preferred Stock. As of December 31, 2025, the redemption had not yet been completed. We currently estimate the final redemption amount to be approximately $50,000 after permitted expenses and net asset recoveries. Redemption will require the use of cash that might otherwise be available for operations or strategic alternatives. The existence of these securities may affect the market price of our common stock and could complicate the negotiation or completion of a strategic transaction. Any strategic transaction may also require the issuance of additional equity securities, which could result in further dilution to existing common stockholders.

*The market price of our common stock may be volatile.*

The market price of our common stock has experienced significant fluctuations and may continue to fluctuate due to a variety of factors, many of which are beyond our control. These factors may include:

* developments
 relating to our Strategic Transaction process;

* our
 ability to obtain additional financing;

* our
 liquidity position and financial condition;

* our
 compliance with Nasdaq listing requirements;

* announcements
 regarding executive leadership or key personnel;

* general
 market and economic conditions; and

* changes
 in investor perception of companies with limited operations or
 transitional business models.

In addition, stock markets in general have experienced significant price and volume volatility that may be unrelated to the operating performance of particular companies. These fluctuations may adversely affect the market price of our common stock.

*The issuance of additional equity or the exercise or conversion of outstanding securities may result in substantial dilution.*

We have outstanding securities, including options and warrants, that may be convertible into or exercisable for shares of our common stock. In addition, we may issue additional equity securities in connection with financing transactions, Strategic Transactions, or other corporate purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The issuance of additional shares of common stock or securities convertible into common stock could result in substantial dilution to existing stockholders and may adversely affect the market price of our common stock.

*Future issuances of equity securities could dilute existing stockholders and adversely affect the market price of our common stock.*

We may issue additional shares of common stock or securities convertible into or exercisable for common stock in connection with financing transactions, Strategic Transactions, or other corporate purposes. The issuance of additional shares may dilute the ownership interests of existing stockholders and could adversely affect the market price of our common stock. Sales of substantial amounts of our common stock in the public market, or the perception that such sales may occur, could also negatively impact the trading price of our common stock.

------

[**Table of Contents**](#TOC)

*The absence of equity research coverage or unfavorable analyst commentary could adversely affect the market price of our common stock.*

The trading market for our common stock may be influenced by research reports and recommendations published by equity research analysts. We do not control the content of analyst reports. If one or more analysts downgrade our common stock, issue unfavorable commentary, or cease coverage, the market price and liquidity of our common stock could decline.

*A Strategic Transaction may result in significant dilution to existing stockholders or a change in control of the Company.*

The completion of a Strategic Transaction may require the issuance of a substantial number of shares of our common stock or securities convertible into or exercisable for common stock or may otherwise result in a change in the Company's capital structure. Any such issuance could result in significant dilution to existing stockholders, including a reduction in voting power, economic interest, and ownership percentage.

In addition, a Strategic Transaction could result in a change in control of the Company, including the issuance of securities that represent a majority of our outstanding voting power or the appointment of new directors or management. A change in control could materially alter our business strategy, governance structure, and risk profile. There can be no assurance that any Strategic Transaction would enhance stockholder value or that its terms would be favorable to all stockholders.

*Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the exclusive forum for certain stockholder litigation, which may limit stockholders' ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.*

Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any derivative action or proceeding brought on behalf of the Company;

(ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee, or agent of the Company to the Company or our stockholders;

(iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation, or our bylaws; or

(iv) any action asserting a claim governed by the internal affairs doctrine.

These exclusive forum provisions do not apply to claims arising under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, or any other claim for which federal courts have exclusive jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The exclusive forum provision may limit a stockholder's ability to bring a claim in a judicial forum that it finds favorable and may increase costs associated with bringing such a claim. If a court were to determine that the exclusive forum provision is inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions.

[**ITEM 1B. UNRESOLVED STAFF COMMENTS**](#)

Not applicable.

------

[**Table of Contents**](#TOC)

[**ITEM 1C. CYBERSECURITY**](#)

The Company maintains information technology systems and third-party hosted platforms that support its financial reporting, public company compliance, warranty servicing activities, and administrative functions. Although the Company's operating activities have been significantly reduced following the October 2025 asset disposition, it continues to rely on information systems for accounting, reporting, communications, and data management.

The Company's cybersecurity strategy is focused on risk identification, protection, detection, incident response, and system resiliency. The Company utilizes internal personnel and, where appropriate, third-party service providers to operate and maintain its information technology infrastructure and to evaluate, test, and update information security processes.

The Company assesses cybersecurity risks as part of its overall risk management framework. Management monitors and evaluates cybersecurity threats through periodic reviews of system access controls, third-party service provider security measures, and applicable industry practices. The Company is not currently aware of any cybersecurity incidents that have materially affected, or are reasonably likely to materially affect, the Company's business strategy, results of operations, or financial condition.

The Audit Committee of the Board of Directors provides oversight of the Company's cybersecurity risk management.The Audit Committee periodically discusses cybersecurity risks and mitigation measures with management and, as appropriate, external advisors.

[ITEM 2. PROPERTIES](#)

Following the disposition of certain operating assets in October 2025, the Company transitioned to a significantly reduced operational structure. The Company has terminated or settled two of its prior operating leases and continues to evaluate sublease or mitigation opportunities for its remaining facility where appropriate.

The Company leases approximately 9,402 square feet of office space in Salt Lake City, Utah under an operating lease expiring in February 2028. This facility supports the Company's remaining administrative functions, public company compliance activities, and limited operational support functions. The Company is evaluating sublease opportunities with respect to this facility.

The Company previously leased a 2,590 square-foot warehouse facility in Salt Lake City, Utah (363 West 2720 South, Suite B) under an operating lease scheduled to expire in February 2028. On February 24, 2026, the Company entered into an Early Termination Agreement with the landlord that terminated the lease effective midnight February 28, 2026. In connection with the early termination, the Company paid a buyout of $43 and forfeited its security deposit. The Company has no further liability under this lease after February 28, 2026. This facility previously supported warranty servicing and repair activities related to products sold prior to the October 2025 asset disposition.

The Company previously leased a 1,350 square-foot facility in Gainesville, Florida under an operating lease that had been extended to February 29, 2029. On March 2, 2026, the Company entered into a Settlement, Release and Agreement to Terminate Lease with the landlord. Pursuant to the settlement, the Company paid $30 and forfeited its security deposit in exchange for full termination of the lease and a mutual release of all obligations. The Company has no further liability under this lease. The facility was no longer utilized for active research and development activities.

The Company previously occupied a 6,175 square-foot facility in Chennai, India under the terms of an operating lease which expired September 2025. This facility supported our administrative, marketing, customer support, and research and product development activities. We did not renew the lease and vacated these premises on November 15, 2025 and the deposit was refunded January 2026.

The Company believes its current facilities are sufficient to support its reduced operations. However, the Company may seek to sublease or otherwise reduce its lease obligations as part of its ongoing efforts to manage costs and preserve liquidity.

[**ITEM 3. LEGAL PROCEEDINGS**](#)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; See Note 9 – Commitments and Contingencies of the Notes to Consolidated Financial Statements (Part II, Item 8) for information regarding legal proceedings in which we are involved, which is incorporated in this Item 3 by reference.

[**ITEM 4. MINE SAFETY DISCLOSURES**](#)

Not Applicable.

------

[**Table of Contents**](#TOC)

[**PART II**](#TOC)

[**ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**](#TOC)

**Market Information**

Our common stock is traded on the Nasdaq Capital Market under the symbol "CLRO". As of March 31, 2026, there were 2,675,412 shares of our common stock issued and outstanding held by approximately 288 holders of record. Each broker dealer or clearing corporation that holds shares for customers is counted as a single holder of record.

**Dividends**

The Company's Board of Directors declared and paid another special dividend of $0.50 per share of the Company's common stock and eligible warrants that was paid on April 10, 2024 to shareholders and warrant holders of record on April 2, 2024.

We do not currently anticipate paying regular cash dividends on our common stock. Any future determination regarding the declaration and payment of dividends will be at the discretion of our Board of Directors and will depend on our financial condition, results of operations, capital requirements, contractual restrictions, and other factors deemed relevant by the Board.

**Issuer Purchases of Equity Securities**

None.

**Sales of Unregistered Securities** 

All sales of unregistered securities were previously reported in Forms 8-K.

**Equity Compensation Plan Information.**

Information about the Company's equity compensation plans required by Item 201(d) of Regulation S-K is set forth under Part III, Item 12 of this Annual Report on Form 10-K.

[**ITEM 6. RESERVED**](#TOC)

[**ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**](#TOC)

The following discussion should be read in conjunction with our consolidated financial statements and related notes included in this report, as well as our other filings with the SEC. This discussion contains forward-looking statements based on current expectations that involve risks and uncertainties, such as our plans, objectives, expectations, and intentions, as set forth under "SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS." Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in the following discussion and under the caption "Risk Factors" in Item 1A and elsewhere in this report.

------

[**Table of Contents**](#TOC)

**OVERVIEW**

The year ended December 31, 2025 was a transformational period for ClearOne, Inc. ("ClearOne," the "Company," "we," "us" or "our"). On October 24, 2025, the Company completed the sale of certain intellectual property, product inventory, and non-exclusive rights to customer data (the "Asset Sale"). As a result of the Asset Sale, the Company no longer manufactures or sells products and maintains a limited inventory and provides customer support services to satisfy warranty claims. The financial results of the disposed operations are reflected as discontinued operations in the Company's consolidated financial statements for all periods presented.

Following the Asset Sale, the Company's continuing activities consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the Company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance. These activities are transitional in nature and are not expected to generate material revenue.

The Company is actively evaluating strategic alternatives intended to enhance stockholder value. These alternatives may include without limitation one or more special transactions, an investment in, or an acquisition of a private operating company, additional asset sales, or other actions that maximize value for stockholders. The closing of the Asset Sale on October 24, 2025 triggered the mandatory redemption of all outstanding shares of the Company's Class A Redeemable Preferred Stock. The Company currently estimates the final redemption amount will be approximately $50 after permitted expenses and net asset recoveries.

**Discontinued Operations** 

**Description of Disposed Assets**

The disposed assets consisted of the Company's historical operations related to conferencing, collaboration, and network streaming products, including product development, manufacturing, sales, and support activities. These operations historically generated the majority of the Company's revenue.

**Timing and Classification**

The Company classified the disposed assets as held for sale and discontinued operations during the third quarter of 2025. The sale closed on October 24, 2025. Accordingly, the results of the disposed assets are presented as discontinued operations for all periods presented, with a hard cutoff on the legal closing date of October 24, 2025. No allocation or smoothing of results has been applied.

**Financial Impact**

The discontinued operations incurred operating losses during 2025 and prior periods. In connection with the Asset Sale, the Company recognized a loss on sale in the fourth quarter of 2025 (primarily driven by inventory carrying values exceeding the $3.0 million gross proceeds, after the $10.7 million impairment charge recorded in the third quarter of 2025). The results of discontinued operations include operating losses incurred prior to closing, inventory write-downs, severance and restructuring costs, and the loss on sale. See Note 2 to the consolidated financial statements for additional information regarding discontinued operations, including the components of the loss on disposal.

The following table summarizes the results of discontinued operations (in thousands):

---

| | | |
|:---|:---|:---|
| | **Year Ended December 31, 2025** | **Year Ended December 31, 2024** |
| Revenue | $6009 | $11386 |
| Gross profit (loss) | $(3021) | $2823 |
| Operating loss | $(10317) | $(7076) |
| Loss on sale of assets | $(11143) | $— |
| Loss from discontinued operations, net of tax | $(21460) | $(7076) |

---

------

[**Table of Contents**](#TOC)

**Continuing Involvement**

Following the Asset Sale, the Company continues to service warranty claims and provide technical support related to products sold prior to October 24, 2025. The Company retained a limited amount of inventory solely to fulfill these obligations. These activities are reported in continuing operations and do not constitute ongoing operations of the disposed assets.

**DISCUSSION OF RESULTS OF OPERATIONS**

**Discontinued Operations**

**Year Ended December 31, 2025 Compared to Year Ended December 31, 2024**

Revenue from discontinued operations decreased significantly in 2025 compared to 2024 due to the disposition of operating assets and the cessation of revenue-generating activities associated with the disposed assets on October 24, 2025. Gross margin and operating results were negatively impacted by reduced sales volume prior to disposition, inventory write-downs, severance and restructuring costs, and the loss on sale recognized in the fourth quarter of 2025. As a result, discontinued operations reported a substantial net loss for the year ended December 31, 2025.

**Continuing Operations**

Following the Asset Sale, continuing operations generated no revenue during the fourth quarter of 2025. Operating expenses consisted primarily of public-company compliance costs, legal and professional fees, warranty servicing and technical support costs, and general and administrative expenses related to the significantly reduced workforce. Because continuing operations are limited in scope and do not generate revenue, period-to-period comparisons are not meaningful.

**LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION**

**Liquidity Position**

As of December 31, 2025, the Company had cash and cash equivalents, and restricted cash of $0.74 million. The Company's primary liquidity requirements relate to ongoing public-company compliance and reporting costs, warranty servicing obligations, professional fees (including legal and investment banking), lease payments on the remaining facilities, the $57,500 severance obligation to the former CEO, and the required redemption of the Class A Redeemable Preferred Stock with any net proceeds from the Asset Sale.

Net proceeds from the Asset Sale are contractually required to be used to redeem all outstanding shares of the Company's Class A Redeemable Preferred Stock. The Asset Sale closed on October 24, 2025, triggering the mandatory redemption of the Class A Redeemable Preferred Stock. As of December 31, 2025, the redemption had not yet been completed. The Company currently estimates the final redemption amount at approximately $50,000 after permitted expenses and net asset recoveries. The redemption payment will occur subsequent to December 31, 2025 and is treated as a non-recognized subsequent event.

Subsequent to year-end, on March 11, 2026, the Company closed a private placement with First Finance Ltd. (its largest stockholder) for aggregate gross proceeds of $1.75 million through the issuance of 437,500 shares of common stock at $4.00 per share and a warrant to purchase up to 437,500 additional shares at $5.00 per share. Of the proceeds, $500,000 became immediately available, with the remaining $1.25 million available upon completion of the Company's reincorporation from Delaware to Nevada. This financing provides an additional source of short-term liquidity.

**Cash Flows**

Net cash used in operating activities during 2025 primarily resulted from operating losses, restructuring activities, and costs associated with discontinued operations. Net cash provided by investing activities primarily reflects the $3.0 million gross proceeds from the October 2025 Asset Sale (net of transaction costs). The Company did not have committed sources of financing during 2025.

Subsequent to year-end, on March 11, 2026, the Company closed a private placement with its largest stockholder for aggregate gross proceeds of $1.75 million (see Liquidity, Capital Resources and Financial Position and Note 17 – Subsequent Events for additional information).

------

[**Table of Contents**](#TOC)

**Capital Resources and Going Concern**

The Company has incurred significant losses and negative cash flows from operations. These conditions, the limited nature of continuing operations, the mandatory redemption obligation for the Class A Redeemable Preferred Stock (triggered by the October 24, 2025 Asset Sale closing), and the absence of committed sources of financing raise substantial doubt about the Company's ability to continue as a going concern within one year after the issuance date of the consolidated financial statements.

Subsequent to year-end, on March 11, 2026, the Company closed a private placement with its largest stockholder for aggregate gross proceeds of $1.75 million (see Liquidity, Capital Resources and Financial Position and Note 17 – Subsequent Events for additional information). This financing provides a partial source of short-term liquidity.

Management is actively evaluating strategic alternatives intended to enhance stockholder value and improve the Company's liquidity position. These alternatives may include one or more special transactions or other actions that maximize value for stockholders. There can be no assurance that the Company will successfully complete any transaction or that any such transaction will provide sufficient liquidity to continue operations.

If the Company is unable to complete a special transaction, satisfy the conditions for the remaining financing proceeds, or otherwise obtain additional capital on acceptable terms, management may be required to significantly curtail operations or pursue an orderly wind-down of operations. The consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.

**Contractual Obligations and Commitments**

The Company's contractual obligations as of December 31, 2025 primarily consist of operating lease obligations for the three remaining facilities, warranty obligations, and legal settlement obligations. A summary of the Company's contractual obligations is included in the table below (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** |
|  | **Total** | **Less Than**<br> **1 Year** | **1-3 Years** | **3-5 Years** | **More than 5**<br> **years** |
| Operating lease obligations  | $513 | $223 | $290 | $— | $— |
| Purchase obligations  |  |  |  |  |  |
| Total  | $513 | $223 | $290 | $— | $— |

---

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES** 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses. The Company's most significant accounting estimates include:

* Classification
 of and accounting for discontinued operations and the Asset Sale (ASC
 205-20 and ASC 360)

* Impairment
 of long-lived assets and inventory valuation related to retained warranty
 inventory

* Warranty
 reserves

* Legal
 contingencies and settlements

* Going-concern
 assessment (ASC 205-40)

Actual results could differ materially from these estimates.

**Off-Balance Sheet Arrangements**

The Company does not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on its financial condition, results of operations, liquidity, or capital resources.

**Recent Accounting Pronouncements**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For descriptions of recently issued accounting standards, see Note 1 – Business Description, Basis of Presentation and Significant Accounting Policies of our Notes to Consolidated Financial Statements.

------

[**Table of Contents**](#TOC)

**IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS**

For descriptions of recently issued accounting standards, see <u>Note 1. Business Description, Basis of Presentation and Significant Accounting Policies</u> of our Notes to Consolidated Financial Statements.

[**ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**](#TOC)

Not Applicable

[**ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA**](#TOC)

Financial statements and supplementary data required by this are included herein as a <u>separate section</u> of this Form 10-K, beginning on page F-1, and are incorporated in this Item 8 by reference.

[**ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE**](#TOC)

None.

[**ITEM 9A. CONTROLS AND PROCEDURES**](#TOC)

***Evaluation of Disclosure Controls and Procedures***

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized, and reported within the required time periods, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. As required by Rule 13a-15 under the Exchange Act, we have completed an evaluation, under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness and the design and operation of our disclosure controls and procedures as of December 31, 2025. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Annual Report, our disclosure controls and procedures were effective at a reasonable assurance level as of December 31, 2025.

The effectiveness of any system of disclosure controls and procedures is subject to certain limitations, including the exercise of judgment in designing, implementing, and evaluating the controls and procedures, the assumptions used in identifying the likelihood of future events, and the inability to eliminate improper conduct completely. A controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a Company have been detected. As a result, there can be no assurance that our disclosure controls and procedures will detect all errors or fraud.

***Management's Annual Report on Internal Control Over Financial Reporting***

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2025 based on the framework set forth in *Internal Control - Integrated Framework* (2013 framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment using that criteria, management concluded that the design and operation of our internal control over financial reporting were effective as of December 31, 2025.

------

[**Table of Contents**](#TOC)

***Changes in Internal Control Over Financial Reporting***

There were no changes in our internal control over financial reporting that occurred during the fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

[**ITEM 9B. OTHER INFORMATION**](#TOC)

**(a)** None.

**(b)** None

[**ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.**](#TOC)

(a) Not applicable.

(b) Not applicable.

------

[**Table of Contents**](#TOC)

[**PART III**](#)

[**ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**](#)

The following table sets forth certain information regarding our directors and executive officers as of March 31, 2026.

---

| | | | |
|:---|:---|:---|:---|
| **Name**  | **Age**  | **Position**  | **Director or Officer Since**  |
| Derek L. Graham  | 58 | Chief Executive Officer  | 2022 |
| Eric L. Robinson  | 59 | Chairman, and Director \*  | 2015 |
| Lisa B. Higley | 58 | Director | 2020 |
| Bruce Whaley  | 75 | Director \*  | 2019 |
| Eric Boehnke | 60 | Director | 2025 |
| Youngsun "Sunny" Park | 55 | Director  | 2025 |
| Simon Brewer | 47 | Chief Financial Officer  | 2024 |

---

\* Member of the Audit and Compliance Committee, Compensation Committee and Nominating Committee 

**Derek L. Graham** is our Chief Executive Officer. He was appointed as Interim CEO in May 2022 and was confirmed as permanent CEO in January 2023. He joined our company in July 2003 as Lead Engineer for Conferencing Cameras. In 2004, he was promoted to Engineering Operations Manager. In 2006, he was promoted to Director of Research and Development. In 2007, he was promoted to Sr. Director of Research and Development. In 2009, he was promoted to Vice President of Research and Development. In 2011, he was promoted to Sr. Vice President of Research and Development. In those prior roles, Derek was responsible for funding, staffing, and execution of parallel engineering programs that resulted in successful development of professionally installed audio and video conferencing, video streaming, wireless microphone, digital signage, and camera products. Derek is a named inventor on 13patents. Prior to joining ClearOne, Derek held engineering and management positions at Intel Corporation in the areas of audio conferencing and telephony technologies. Mr. Graham earned a Bachelor of Science in Electrical Engineering, with highest honors, and a Master's Degree in Electrical Engineering from the Georgia Institute of Technology.

**Eric. L Robinson** has served as a director of since July 2015 and Chairman since February 2022. Mr. Robinson spent fourteen years in private practice as a corporate attorney, including eleven years as a partner in the Salt Lake City, Utah law firm of Blackburn & Stoll, LC. Mr. Robinson's law practice focused on securities, corporate and other business transactions. For the past five years, Mr. Robinson has been principally employed by MicroPower Global Limited, a company in the semiconductor business, OUR Rescue, Inc. and as a private attorney. At MicroPower, Mr. Robinson acted as General Counsel, Chief Financial Officer and a director. At OUR Rescue, Inc. he acts as VP of Legal Affairs. Mr. Robinson also maintains a law practice and serves as counsel to a number of companies in the fields of regenerative medicine and commercial construction. Mr. Robinson previously served as chief financial officer, in-house counsel, secretary and treasurer of ActiveCare, Inc. from July 2016 until his voluntary resignation in June 2017, and subsequent to Mr. Robinson's departure, ActiveCare filed a voluntary bankruptcy petition under Chapter 11 of the U.S. Bankruptcy Code on July 15, 2018. His legal practice included working with companies in connection with public and private offerings of securities, corporate partnering, mergers and acquisitions, licensing technology transfer, contracts and construction. He graduated from the University of Utah with honors with a B.S. degree in accounting and he subsequently passed the CPA exam (unlicensed). He graduated from Vanderbilt University with a J.D. where he graduated Order of the Coif and acted as a Managing Editor of the Law Review. Mr. Robinson has previously served as corporate and securities legal counsel to the Company and the Company's largest shareholder, E. Dallin Bagley.

**Lisa B. Higley** was appointed a director effective July 20, 2020. Ms. Higley has been self-employed as a CPA since June 2009. Previously, she was the CFO for Daisy D's Paper Company from March 2007 until January 2009, where she managed all aspects of the company's financial and accounting responsibilities. Additionally, Ms. Higley was the CFO for Tunex International from April 2006 to March 2007 where she was accountable for all financial aspects of the corporation. Prior to that, Ms. Higley was a staff tax accountant at Wisen, Smith, Racker & Prescott LLP from February 2004 to April 2006. Ms. Higley earned her Bachelor of Science in Accounting from the University of Oregon and her MBA from Utah State University, and has been a Utah CPA since 2004. Ms. Higley is the daughter of Edward D. Bagley, our former Chairman of the Board. Mr. Edward D. Bagley beneficially owns5.3% of our issued and outstanding common stock.

------

[**Table of Contents**](#TOC)

**Bruce Whaley** was appointed a director effective April 16, 2019. Mr. Whaley has extensive experience as a stockbroker for nearly five decades. Mr. Whaley is currently a broker trading at Wilson & Davis, a regional brokerage firm based in Salt Lake City, Utah. He has been with Wilson & Davis since 1988. Until March 2023, Mr. Whaley also held a real estate license and worked as a real estate agent for Coldwell Banker. Mr. Whaley attended the University of Utah between 1968 and 1971 and studied many subjects including business administration, accounting and finance. He did not graduate with a degree.

**Eric Boehnke** was appointed to the Board on June 20, 2025. Mr. Boehnke is the principal of Big Sky Management Ltd., a corporate finance advisory firm he founded in 1999. Over his 25-year career, Mr. Boehnke has served as an officer and director of multiple public companies listed on the Toronto Stock Exchange, Canadian Securities Exchange, and NASDAQ. He has extensive experience in corporate finance, including debt and equity financings, initial public offerings, and mergers and acquisitions, having raised more than $500 million in capital across various business sectors. Mr. Boehnke holds a B.Sc. from the University of Toronto.

 **Youngsun "Sunny" Park** was appointed to the Board on June 20, 2025. Ms. Park is a seasoned attorney with over two decades of experience in estate planning, tax law, civil litigation, and legal strategy, supplemented by extensive public policy and governance experience. She served as Mayor of Buena Park, California (the first Asian American Pacific Islander woman to hold the position) and as a City Council Member from 2018 to 2022. She currently serves as a housing attorney at Community Legal Aid SoCal, handling civil litigation, federal housing policy, and property-related disputes. Previously, she was Of Counsel at Asher Law Group in Century City, California, advising high-net-worth individuals and business owners on estate planning, succession strategies, and asset protection from 2007 to 2023. Ms. Park also held appointments to the California Board of Accountancy (2017–2018), the Orange County Fire Authority (2021–2022), and the Southern California Association of Governments (2021–2022). She holds an LL.M. in Taxation from New York University School of Law, a J.D. from Golden Gate University, and a B.A. from Yonsei University.

**Simon Brewer** was appointed Chief Financial Officer of ClearOne Inc. in April 2024, bringing over 25 years of experience in finance, operations, and leadership across technology, manufacturing, e-commerce, biotech, and non-profit sectors. He oversees the company's finance and accounting functions, helping drive strategic initiatives to position ClearOne for scalable growth. Prior to ClearOne, Mr. Brewer was CFO and COO at an international non-profit dedicated to eradicating human trafficking (2021–2024), and CFO at Predictive Technology Group Inc. (2018–2021), leading its transition to a public company. He also held CFO roles at Norbest LLC (2016–2018) and senior finance and IT positions at Wilson Electronics (2013–2016) and Backcountry.com (2009–2013), consistently achieving revenue growth and operational efficiencies. Mr. Brewer transitioned to a dedicated accounting career at KPMG LLP (2005–2009), managing audits and advisory for high-profile clients, after beginning his career in 1999 as a programmer and accountant at Prospect Planet Dotcom. He holds a Master of Accounting and a Bachelor of Arts in Accounting (Cum Laude) with a Minor in Russian from the University of Utah and is a Certified Public Accountant (CPA) in Utah and Nevada and a Chartered Global Management Accountant (CGMA).

**Section 16(a) Beneficial Ownership Reporting Compliance**

Section 16(a) of the Securities Exchange Act, of 1934 as amended, requires our directors, executive officers and persons who own more than 10% of a registered class of our equity securities to file with the SEC initial reports of ownership on Form 3 and reports of changes of ownership of our equity securities on Forms 4 and 5. Officers, directors, and greater than 10% shareholders are required to furnish us with copies of all Section 16(a) reports they file. Based solely on a review of the reports furnished to us for the year ended December 31, 2025, we believe that each person who, at any time during such fiscal year was a director, officer, or beneficial owner of more than 10% of our common stock complied with all Section 16(a) filing requirements during such period, except for the following forms:

---

| | | | |
|:---|:---|:---|:---|
| **Filer** | **Form** | **Due Date**  | **Filing Date**  |
| Eric Boehnke  | 3 | 06/30/2025 | 12/30/2025 |
| Youngsun "Sunny" Park  | 3 | 06/30/2025 | 08/18/2025 |
| First Finance LTD. | 3 | 06/30/2025 | 11/26/2025 |
| Andrew Hromyk<br>| 3 | 06/30/2025 | 11/26/2025 |

---

------

[**Table of Contents**](#TOC)

**Code of Ethics**

The Board of Directors adopted a code of ethics that applies to our Board of Directors, executive officers, and employees. The Company's Code of Ethics is posted on our website at www.clearone.com.

**Insider Trading Policies and Procedures**

The Company has adopted a Statement of Policy Regarding Compliance with Insider Trading Laws (the "Insider Trading Policy) that establishes policies and procedures governing the purchase, sale, and/or other dispositions of the Company's securities by directors, officers and employees. The Insider Trading Policy requires compliance with all applicable laws, rules and regulations governing the offer and sale of securities and prohibits directors, officers and employees from engaging in transactions in the Company's securities while in possession of material nonpublic information. The Insider Trading Policy establishes quarterly blackout periods during which trading in the Company's securities is prohibited. These blackout periods begin 15 days prior to the end of each fiscal quarter and ends at the opening of trading on the first business day after the public dissemination of Company's financial results for that quarter for a full trading day. In addition, the Insider Trading Policy requires senior officers and key employees to obtain pre-approval of any transactions in Company securities from the Company's Compliance Officer under the Insider Trading Policy, which currently is the Chief Financial Officer.

**Nomination Procedures**

No changes have been made to the procedures by which our shareholders may recommend nominees to our Board of Directors.

**Audit and Compliance Committee**

The Company has a separate Audit and Compliance Committee and its members are Eric L. Robinson (Chairman) and Bruce Whaley. The Board has determined that Eric L. Robinson is an "audit committee financial expert" and each member is independent in accordance with applicable rules and regulations of Nasdaq and the SEC.

[**ITEM 11. EXECUTIVE COMPENSATION**](#)

**EXECUTIVE COMPENSATION**

The following table sets forth the compensation paid or earned by each named executive officer for the years ended December 31, 2025 and 2024.

**SUMMARY COMPENSATION TABLE**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position**  | **Salary**  | **Option Awards**  | **Non-Equity Incentive Plan Compensation**  | **All Other Compensation**  | **Total**  |
| **Derek Graham, Chief Executive Officer<sup>(1)</sup>** |  |  |  |  |  |
| Year ended December 31, 2025 | $249749 | $— | $— | $— | $249749 |
| Year ended December 31, 2024 | $238621 | $24336 | $— | $20096<sup>(3)</sup> | $283053 |
| **Simon Brewer - Chief Financial Officer<sup>(2)</sup>** |  |  |  |  |  |
| Year ended December 31, 2025  | $307477 | $— | $— | $— | $307477 |
| Year ended December 31, 2024 | $193846 | $40560 | $— | $— | $234406 |

---

(1) Derek L. Graham was appointed as Interim CEO on May 24, 2022 and became permanent CEO on Jan 26, 2023. 

(2) Simon Brewer was appointed Chief Financial Officer on April 15, 2024.

(3) Bonuses reflect achievement of specific performance metrics approved by the Compensation Committee.

*Executive Separations and Rehirings (Subsequent Event)*

On December 31, 2025, the Company terminated the employment of Derek Graham (Chief Executive Officer). Mr. Graham received severance of $57,500 (three months base salary), which was accrued at December 31, 2025. Mr. Graham was rehired effective January 2, 2026 under a new employment agreement. A retention bonus was granted to Mr. Graham, contingent upon finishing projects on an agreed upon timeframe.

On December 31, 2025 the Company terminated the employment of Simon Brewer (Chief Financial Officer). Mr. Brewer received no material severance. Mr. Brewer was rehired effective January 1, 2026 under a new employment agreement. Mr. Brewer received a $75,000 sign-on bonus paid on January 9, 2026. A retention bonus was granted to Mr. Brewer, contingent upon the closing of a future transaction of the Company.

------

[**Table of Contents**](#TOC)

**OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END**

The following table provides information on the holdings of stock options by the named executive officers as of December 31, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Number of Securities Underlying Unexercised Options**  | **Number of Securities Underlying Unexercised Options**  | **Option Exercise Price ($)** | **Option Grant Date** | **Option Expiration Date** |
| **Name** | **Exercisable**  | **Unexercisable**  | **Option Exercise Price ($)** | **Option Grant Date** | **Option Expiration Date** |
| Derek Graham  | 667 |  | 37.500 | 12-14-2020 | 12-14-2026 |
|  | 1666 | 334<sup>(1)</sup> | 15.150 | 06-15-2023 | 06-15-2029 |
|  | 4000 |  | 7.350 | 11-27-2024 | 11-26-2030 |
| Simon Brewer | 6667 |  | 7.350 | 11-27-2024 | 11-26-2030 |

---

(1) One-third of the shares underlying each stock option vest on the first anniversary of the grant date and the remaining shares vest equally over a period of 24 months following the first anniversary of the grant date. 

**OPTION EXERCISES AND STOCK VESTED**

There were no exercises of stock options by named executive officers during 2025.

**DIRECTOR COMPENSATION**

The following table summarizes the compensation paid to non-employee directors for the year ended December 31, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**  | **Fees Earned or Paid in Cash**  | **Option Awards**  | **Other Compensation**  | **Total**  |
| Eric L. Robinson  | $54000 | $— | $— | $54000 |
| Lisa B. Higley | 54000 |  |  | 54000 |
| Eric Boehnke  |  |  |  |  |
| Bruce Whaley  | 33600 |  |  | 33600 |
| Youngsun Park | 17267 |  |  | 17267 |

---

All directors are reimbursed by the Company for their out-of-pocket travel and related expenses, if any, incurred in attending all Board of Directors and committee meetings. However, during 2025 no expenses were reimbursed to any director.

[**ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS**](#)

The following table sets forth certain information regarding ownership of our common stock as of March 31, 2026, except as otherwise stated, by (i) each director and nominee for director, (ii) the named executive officers, (iii) all of our named executive officers and directors as a group, and (iv) each person known to us to be the beneficial owner of more than 5% of our outstanding common stock.

------

[**Table of Contents**](#TOC)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Shares Beneficially Owned**  | **Shares Beneficially Owned**  |  |  |  |
|  | **Currently Owned**  | **Currently** **Owned Percent<sup>(2)</sup>** | **Shares that could be acquired within 60 days**  | **Total** | **Percent** |
| **Name of Beneficial Owner <sup>(1)</sup>** | (A)  | (B)  | (C)  | (D)  | (E)  |
|  **<u>Directors and Executive Officers:</u>**  |  |  |  |  |  |
| Derek L. Graham  | 351 | 0.00% | 6333 | 6684 | 0.03% |
| Eric L. Robinson  | 5 | 0.00% | 2001 | 2006 | 0.01% |
| Lisa B. Higley<sup>(3)</sup> | 1633 | 0.01% | 667 | 2300 | 0.01% |
| Eric Boehnke  |  | —% |  |  | —% |
| Bruce Whaley  | 800 | 0.00% | 667 | 1467 | 0.01% |
| Youngsun Park |  |  |  |  |  |
| Simon Brewer |  | —% | 6667 | 6667 | 0.03% |
| Total (Directors and Officers)  | 2789 | 0.01% | 16335 | 19124 | 0.09% |
| **<u>5% Shareholders:</u>** |  |  |  |  |  |
| First Finance Ltd. <sup>(4)</sup> | 1641162 | 61.3% |  | 1641162 | 61.3% |
| Edward D. Bagley<sup>(5)</sup>  | 140668 | 5.3% | 2001 | 142669 | 5.3% |

---

(1) Except as otherwise indicated, each person named in the table has sole voting and investment power, subject to applicable community property law. Except as otherwise indicated, each person may be reached at our corporate offices c/o ClearOne, Inc., 5225 Wiley Post Way, Suite 500, Salt Lake City, UT 84116.

(2) The percentages shown in Column (B) are calculated based on shares of common stock outstanding on March 31, 2026. The numbers shown in Column (D) and percentages shown in Column (E) include the shares of common stock actually owned as of March 31, 2026 and the shares of common stock that the identified person or group had the right to acquire within 60 days of such date. In calculating the percentage of ownership, all shares of common stock that each identified person or group had the right to acquire within 60 days of March 31, 2026 upon the exercise of the stock options and warrants shown in Column (C) are deemed to be outstanding for the purpose of computing the percentage of the shares of common stock owned by the persons or groups listed above. 

(3) This information is based upon the Form 4 filed with the SEC as of June 2, 2023. Lisa Higley, who was appointed a Director effective July 20, 2020, is the daughter of Edward D. Bagley, and each of them has previously disclaimed beneficial ownership of common stock beneficially owned by the other. The share amounts indicated for Ms. Higley do not include any shares held by Edward D. Bagley. The share amounts indicated for Ms. Higley do not include 437 shares owned by her spouse and 150,175 shares held by a trust in which she is a co-trustee. 

(4) Beneficial ownership information for First Finance Ltd. based on a Schedule 13D/A filed by First Finance Ltd. On November 26, 2025 and a Schedule 13D/A filed on March 6, 2026. According to the Schedule 13D Amendments, First Finance Ltd. exercises sole investment and dispositive power with respect to all shares. By virtue of his pecuniary interest in First Finance Ltd., Andrew Hromyk may be deemed to beneficially own all of the shares beneficially owned by First Finance Ltd. resulting from Mr. Hromyk's pecuniary interest in First Finance Ltd. as its controlling shareholder and director. The principal business address of First Finance Ltd. and Mr. Hromyk is 520 Newport Center Drive, Suite 650, Newport Beach CA, 92660..

(5) Mr. Bagley may be deemed to own an additional 23,684 shares of Common Stock that his spouse Carolyn Bagley owns individually. Mr. Bagley, however, disclaims beneficial ownership of these shares that may be indirectly beneficially owned by Mr. Bagley and they are excluded from the amounts reported in the table above. Mr. Edward D. Bagley has sole voting and dispositive power over 142,669 shares (including the shares that may be acquired pursuant to exercise of options to purchase 2,001 shares of Common Stock). This information is based upon a Schedule 13D Amendment filed by Mr. Bagley with the SEC on November 26, 2025. Lisa Higley, who was appointed a Director effective July 20, 2020, is the daughter of Edward D. Bagley, and each of them has previously disclaimed beneficial ownership of Common Stock beneficially owned by the other. The share amounts indicated for Mr. Edward D. Bagley do not include any shares held by E. Bryan Bagley or Lisa Higley..

------

[**Table of Contents**](#TOC)

Equity Compensation Plan Information

The following table summarizes information, as of December 31, 2025, relating to equity compensation plans of the Company (including individual compensation arrangements) pursuant to which equity securities of the Company are authorized for issuance.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;**Plan Category** | **(a)**<br>**Number of securities to be issued upon exercise of outstanding options and rights** | **(b)**<br>**Weighted-Average Exercise Price of Outstanding Options and Rights** | **(c)**<br>**Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column(a))** |
| Equity Compensation Plans Approved by Stockholders | 19715 | $35.33 | 1980285 |
| Equity Compensation Plans Not Approved by Stockholders |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 19715 | $35.33 | 1980285 |

---

[**ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE**](#)

We recognize that transactions between us and any of our directors, executives or other related persons can present potential or actual conflicts of interest and create the appearance that our decisions are based on considerations other than the best interests of our Company and shareholders. Therefore, as a general matter and in accordance with our Code of Ethics, it is our preference to avoid such transactions. Nevertheless, we recognize that there are situations where such transactions may be in, or may not be inconsistent with, the best interests of our Company. Under the terms of its charter, our Audit and Compliance Committee reviews and, if appropriate, approves or ratifies any such transactions. Pursuant to the charter, the Committee will review any transaction in which we are or will be a participant and the amount involved exceeds $120,000, and in which any of our directors or executives had, has or will have a direct or indirect material interest. After its review, the Committee will only approve or ratify those transactions that are in, or are not inconsistent with, the best interests of our Company and our shareholders, as the Committee determines in good faith. The Company's Board of Directors adopted the Company's Related Party Transactions Policy on January 18, 2017. This policy is available on our website at http://investors.clearone.com/corporate-governance.

**Related Party Transactions**

On June 3, 2015, the Company entered into a Consulting Agreement with Edward D. Bagley, former Chairman of the Board and greater than 10% shareholder ("Consulting Agreement") which became effective on July 29, 2015 for an initial term of three years which was renewed in 2018 for an additional term of three years and renewed again in 2021 for an additional term of 3 years through 2024. Pursuant to the terms of the Consulting Agreement Mr. Bagley is paid a fee of $5,000 per month and is eligible to participate in our equity incentive programs and will be granted stock options commensurate with grants of stock options made to our directors. During 2025, he was paid $50,000 as consulting fees. During 2025, he did not receive any grant of stock options. This consulting agreement was terminated in November 2025.

Subsequent to year-end, on March 11, 2026, the Company closed a private placement with First Finance Ltd. (its largest stockholder) for aggregate gross proceeds of $1.75 million through the issuance of 437,500 shares of common stock at $4.00 per share and a warrant to purchase up to 437,500 additional shares at $5.00 per share. Of the proceeds, $500,000 became immediately available, with the remaining $1.25 million available upon completion of the Company's reincorporation from Delaware to Nevada. This financing provides an additional source of short-term liquidity.

------

[**Table of Contents**](#TOC)

**Director Independence**

Our Board of Directors has determined, after considering all the relevant facts and circumstances, that Eric Robinson, Bruce Whaley and Youngsun "Sunny" Park are independent directors, in accordance with the definition of "independence" under the listing standards of NASDAQ, because they have no relationship with us that would interfere with their exercise of independent judgment.

[**ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES**](#)

Amounts:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Audit fees<sup>(1)</sup> | $217655 | $245493 |
| Audit-related fees<sup>(2)</sup> |  |  |
| Tax fees<sup>(3)</sup> | 68527 | 53956 |
| All other fees  |  |  |
| Total  | $286182 | $299449 |

---

(1) Represents fees billed for professional services rendered for the audit and reviews of our financial statements filed with the SEC on Forms 10-K and 10-Q. 

(2) Represents fees billed for consents provided with respect to registration statements and related amendments. 

(3) Represents fees billed for tax filing, preparation, and tax advisory services. 

**Pre-Approval Policies and Procedures**

The Audit and Compliance Committee ensures that we engage our independent registered public accounting firm to provide only audit and non-audit services that are compatible with maintaining the independence of our public accountants. The Audit and Compliance Committee approves or pre-approves all services provided by our public accountants. Permitted services include audit and audit-related services, tax services and other non-audit related services. Certain services are identified as restricted. Restricted services are those services that may not be provided by our external public accountants, whether identified in statute or determined to be incompatible with the role of an independent auditor. All fees identified in the preceding table were approved by the Audit and Compliance Committee. During 2025, the Audit and Compliance Committee reviewed all non-audit services provided by our independent registered public accounting firm and concluded that the provision of such non-audit services was compatible with maintaining the independence of the external public accountants.

------

[**Table of Contents**](#TOC)

[**PART IV**](#)

[**ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES**](#)

1. Financial Statements: Financial statements set forth under Part II, Item 8 of this Annual Report on Form 10-K are filed in a separate section of this Form 10-K. See the "Index to Consolidated Financial Statements".

2. Financial Statement Schedules: All schedules are omitted since they either are not required, not applicable or the information is presented in the accompanying consolidated financial statements and notes thereto.

3. Exhibits: The exhibits listed under the Index of exhibits in the next page are filed or incorporated by reference as part of this Form 10-K.

[**ITEM 16. FORM 10-K SUMMARY**](#)

Not applicable.

------

[**Table of Contents**](#TOC)

**<u>INDEX TO EXHIBITS</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Exhibit**<br> **Number** | **Exhibit Description** | **Form** | **Exhibit Incorporated**<br> **Herein by Reference** | **Filing Date** |
| 3.1 | [<u>Certificate of Incorporation of ClearOne, Inc.</u>](http://www.sec.gov/Archives/edgar/data/840715/000143774918018953/ex_126578.htm) | 8-K | 3.1 | 10/29/18 |
| 3.2 | [Certificate of Amendment to Certificate of Incorporation dated June 2, 2025.](http://www.sec.gov/Archives/edgar/data/840715/000175392625000914/ex31_1.htm) | 8-K | 3.1 | 06/02/25 |
| 3.3 | [Certificate of Amendment to Certificate of Incorporation dated June 20, 2025.](http://www.sec.gov/Archives/edgar/data/840715/000175392625001345/ex34_1.htm) | 10-Q | 3.4 | 08/14/25 |
| 3.4 | [Certificate of Designation for Class A Redeemable Preferred Stock](http://www.sec.gov/Archives/edgar/data/840715/000175392625001008/ex31_1.htm) | 8-K | 3.1 | 06/25/25 |
| 3.5 | [Certificate of Designation for Class B Convertible Preferred Stock](http://www.sec.gov/Archives/edgar/data/840715/000175392625001008/ex32_2.htm) | 8-K | 3.2 | 06/25/25 |
| 3.6 | [<u>Bylaws</u>](http://www.sec.gov/Archives/edgar/data/840715/000143774918018953/ex_126579.htm) | 8-K | 3.2 | 10/29/18 |
| 3.7† | [Amendment No. 1 to Bylaws](ex37_1.htm) |  |  |  |
| 4.1 | [<u>Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</u>](http://www.sec.gov/Archives/edgar/data/840715/000175392620000071/ex41_7.htm) | 10-K | 4.1 | 03/30/20 |
| 4.2 | [Form of Warrant](http://www.sec.gov/Archives/edgar/data/840715/000175392626000443/ex41_1.htm) | 8-K | 4.1 | 3/5/26 |
| 10.1# | [<u>ClearOne, Inc. Equity Incentive Plan</u>](http://www.sec.gov/Archives/edgar/data/840715/000084071516000065/exhibit48eip.htm) | S-8 | 4.8 | 01/26/16 |
| 10.2# | [<u>Amendment No. 1 to the ClearOne, Inc. Equity Incentive Plan</u>](http://www.sec.gov/Archives/edgar/data/840715/000084071515000019/exhibit411amendmentno1equi.htm) | S-8 | 4.11 | 06/30/15 |
| 10.3# | [<u>ClearOne, Inc. Employee Stock Purchase Plan</u>](http://www.sec.gov/Archives/edgar/data/840715/000084071515000022/exhibit43clearoneemployees.htm) | S-8 | 4.3 | 06/30/15 |
| 10.4\* | [<u>Confidential Settlement and License Agreement.</u>](http://www.sec.gov/Archives/edgar/data/840715/000175392622001543/ex101_1.htm) | 8-K | 10.1 | 12/09/22 |
| 10.5\* | [<u>Non-Exclusive Cross License Agreement effective December 23, 2023 by and between ClearOne, Inc. and Sennheiser electronic GmbH & C0. KG.</u>](http://www.sec.gov/Archives/edgar/data/840715/000175392623001643/ex101_1.htm) | 8-K | 10.1 | 12/27/23 |
| 10.6+ | [Securities Purchase Agreement](http://www.sec.gov/Archives/edgar/data/840715/000175392626000443/ex101_2.htm) | 8-K | 10.1 | 3/5/26 |
| 10.7 | [Registration Rights Agreement](http://www.sec.gov/Archives/edgar/data/840715/000175392626000443/ex102_3.htm) | 8-K | 10.2 | 3/5/26 |
| 14.1 | [<u>Code of Ethics, approved by the Board of Directors on August 23, 2006</u>](http://www.sec.gov/Archives/edgar/data/840715/000084071506000045/ex14_1.htm) | 10-K | 14.1 | 09/14/06 |
| 19.1† | [ClearOne Inc. Statement of Policy Regarding Compliance with Insider Trading Laws](http://www.sec.gov/Archives/edgar/data/840715/000175392624000656/ex191_1.htm) | 10-K | 19.1 | 04/01/24 |
| 23.1† | [Consent of Tanner LLP, Independent Registered Public Accounting Firm](ex231_2.htm) |  |  |  |
| 31.1† | [Section 302 Certification of Chief Executive Officer](ex311_3.htm) |  |  |  |
| 31.2† | [Section 302 Certification of Chief Financial Officer](ex312_4.htm) |  |  |  |
| 32.1† | [Section 906 Certification of Chief Executive Officer](ex321_5.htm) |  |  |  |
| 32.2† | [Section 906 Certification of Chief Financial Officer](ex322_6.htm) |  |  |  |
| 97.1† | [Executive Compensation Clawback Policy](ex971_7.htm) |  |  |  |
| 101.INS‡ | XBRL Instance Document |  |  |  |
| 101.SCH‡ | XBRL Taxonomy Extension Schema |  |  |  |
| 101.CAL‡ | XBRL Taxonomy Extension Calculation Linkbase |  |  |  |
| 101.DEF‡ | XBRL Taxonomy Extension Definitions Linkbase |  |  |  |
| 101.LAB‡ | XBRL Taxonomy Extension Label Linkbase |  |  |  |
| 101.PRE‡ | XBRL Taxonomy Extension Presentation Linkbase |  |  |  |
| 104 | The cover page from this Annual Report on Form 10-K formatted in Inline XBRL |  |  |  |

---

\* Certain confidential portions of this exhibit have been excluded from this exhibit in accordance with Rule 24b-2 because such information is (1) not material, and (2) the Company customarily and actually treats that information as private or confidential.

† Filed herewith

+ Schedules and exhibits have been omitted pursuant to Item 601(a)(5) Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the SEC.

‡ Information furnished herewith shall not be deemed to be "filed" for the purposes of Section 18 of the 1934 Act

#Management contract or compensatory plan or arrangement

------

[**Table of Contents**](#TOC)

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CLEARONE, INC.

Registrant

---

| |
|:---|
| */s/ Derek L. Graham* |
| Derek L. Graham |
| Chief Executive Officer |
| March 31, 2026 |

---

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | |
|:---|:---|
| */s/ Derek L. Graham*  | */s/ Simon Brewer* |
| Derek L. Graham | Simon Brewer |
| President and Chief Executive Officer | Chief Financial Officer |
| (Principal Executive Officer) | (Principal Accounting and Principal Financial Officer) |
| March 31, 2026 | March 31, 2026 |
| */s/ Eric L. Robinson* | */s/*Eric Boehnke**  |
| Eric L. Robinson | *Eric Boehnke* |
| Director and Chairman of the Board | Director |
| March 31, 2026 | March 31, 2026 |
| */s/ Bruce Whaley* | */s/ Lisa B. Higley* |
| Bruce Whaley | Lisa B. Higley |
| Director | Director |
| March 31, 2026 | March 31, 2026 |
| */s/ Youngsun "Sunny" Park* |  |
| Youngsun "Sunny" Park |  |
| Director |  |
| March 31, 2026 |  |

---

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

**INDEX TO CONSOLIDATED FINANCIAL STATEMENTS**

---

| | |
|:---|:---|
|  | Page |
| [Report of Independent Registered Public Accounting Firm (PCAOB ID: 270).](#BAA_EVAY4UZ9XC00000000000000000000) | F-1 |
| [Consolidated Balance Sheets as of December 31, 2025 and December 31, 2024](#BBS_LV6K39C84G00000000000000000000) | F-3 |
| [Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2025 and 2024](#BCOMP_AYDW9YHYTS00000000000000000000) | F-4 |
| [Consolidated Statements of Shareholders' Equity for the years ended December 31, 2025 and 2024](#BEQUITY_VYFYECGK8G00000000000000000000) | F-5 |
| [Consolidated Statements of Cash Flows for the years ended December 31, 2025 and 2024](#BCF_GMWSK9YHGG00000000000000000000) | F-6 |
| [Notes to Consolidated Financial Statements](#BNOTES_LWOO6XQXPC00000000000000000000) | F-8 |

---

------

[**Table of Contents**](#TOC)

[**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**](#)

To the Board of Directors and

Stockholders of ClearOne, Inc.:

***Opinion on the Consolidated Financial Statements***

We have audited the accompanying consolidated balance sheets of ClearOne, Inc. and subsidiaries (the "Company") as of December 31, 2025 and 2024, and the related consolidated statements of operations and comprehensive loss, shareholders' equity, and cash flows for each of the years in the two-year period ended December 31, 2025, and the related notes (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

 ***Substantial Doubt about the Company's Ability to Continue as a Going Concern***

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company's present financial situation raises substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

***Basis for Opinion***

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

***Emphasis of Matter – Discontinued Operations***

As discussed in Note 2 to the consolidated financial statements, the Company completed the sale of substantially all of its operating intellectual property, product inventory, and related production assets in October 2025. The results of operations related to the disposed assets have been reported as discontinued operations for all periods presented. Our opinion is not modified with respect to this matter.

\| F-1 \|

------

[**Table of Contents**](#TOC)

***Critical Audit Matter***

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.

---

| |
|:---|
| */s/ TANNER LLP* |
| Lehi, Utah |
| March 31, 2026 |

---

We have served as the Company's auditor since October 14, 2015.

\| F-2 \|

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**CONSOLIDATED BALANCE SHEETS**](#)

**(Dollars in thousands, except par value)**

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2025** | **December 31,**<br>**2024** |
| **ASSETS**  |  |  |
| Current assets:  |  |  |
| Cash and cash equivalents  | $220 | $1417  |
| Restricted cash | 519 |  |
| Inventories, net  | 353  | 392  |
| Assets held for sale |  | 2900 |
| Current assets related to discontinued operations | 604 | 14044 |
| &nbsp;&nbsp;&nbsp; Total current assets  | 1696 | 18753  |
| Operating lease – right of use assets, net  | 494  | 750 |
| Long term assets related to discontinued operations | 109 | 7041 |
| &nbsp;&nbsp;&nbsp; Total assets  | $2299 | $26544  |
| **LIABILITIES AND SHAREHOLDERS' EQUITY**  |  |  |
| Current liabilities:  |  |  |
| Accounts payable  | $30  | $76  |
| Accrued liabilities  | 649  | 360  |
| Current operating lease liability | 223 | 257 |
| Current liabilities related to discontinued operations | 585 | 2852 |
| &nbsp;&nbsp;&nbsp; Total current liabilities  | 1487  | 3545  |
| Operating lease liability, net of current | 290 | 514 |
| Long-term liabilities related to discontinued operations | 1236 | 1154 |
| &nbsp;&nbsp;&nbsp; Total liabilities  | 3013  | 5213  |
| Shareholders' equity:  |  |  |
| Class B convertible preferred stock, par value $0.001, 5,100 shares authorized, — and — shares issued and outstanding, respectively  |  |  |
| Common stock, par value $0.001, 150,000,000 shares authorized, 2,237,912 and 1,599,534 shares issued and outstanding, respectively  | 2  | 2  |
| Additional paid-in capital  | 35767  | 31694  |
| Accumulated other comprehensive loss  | (340) | (306) |
| Accumulated deficit | (36143) | (10059) |
| &nbsp;&nbsp;&nbsp; Total shareholders' equity  | (714) | 21331 |
| &nbsp;&nbsp;&nbsp; Total liabilities and shareholders' equity  | $2299 | $26544  |

---

*See accompanying notes*

\| F-3 \|

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)**](#)

**(Dollars in thousands, except share and per share amounts)**

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,**  | **Year ended December 31,**  |
|  | **2025** | **2024** |
| Continuing operations |  |  |
| &nbsp;&nbsp; Revenue | $—  | $—  |
| &nbsp;&nbsp; Cost of goods sold  | 328  | 194  |
| &nbsp;&nbsp;&nbsp;&nbsp; Gross profit  | (328) | (194) |
| Operating expenses:  |  |  |
| &nbsp;&nbsp;General and administrative | 2453 | 1175 |
| &nbsp;&nbsp;Legal expense | 247 | 247 |
| &nbsp;&nbsp;Professional fees | 1368 | 519 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total operating expenses  | 4068  | 1941  |
| Operating loss  | (4396) | (2135) |
| &nbsp;&nbsp; Interest income (expense), net<br>| (28) | 228 |
| &nbsp;&nbsp; Other income, net  | (117) | 155 |
| &nbsp;&nbsp;&nbsp;&nbsp; Loss from continuing operations before income taxes  | (4541) | (1752) |
| &nbsp;&nbsp; Provision for income taxes  | 83 | 98 |
| &nbsp;&nbsp;&nbsp;&nbsp; Loss from continuing operations | $(4624) | $(1850) |
| &nbsp;&nbsp;&nbsp;&nbsp; Loss from discontinued operations, net of tax | (21460) | (7133) |
| &nbsp;&nbsp;&nbsp;&nbsp; Net loss | (26084) | (8983) |
| Basic loss per common share |  |  |
| &nbsp;&nbsp; From continuing operations  | $(2.62) | $(1.19) |
| &nbsp;&nbsp; From discontinued operations  | $(12.15) | $(4.42) |
| Total | (14.77) | (5.61) |
| Diluted loss per common share  |  |  |
| &nbsp;&nbsp;From continuing operations | $(2.62) | $(1.19) |
| &nbsp;&nbsp; From discontinued operations | (12.15) | (4.42) |
| Total | (14.77) | (5.61) |
| Basic weighted average shares outstanding  | 1765654  | 1598756  |
| Diluted weighted average shares outstanding  | 1765654  | 1598756  |
| Comprehensive loss:  |  |  |
| Net loss | $(26084) | $(8983) |
| Other comprehensive loss:  |  |  |
| &nbsp;&nbsp; Unrealized gain (loss) on available-for-sale securities, net of tax  |  | 17 |
| &nbsp;&nbsp; Change in foreign currency translation adjustment  | (34) | (13) |
| Comprehensive loss | $(26118) | $(8979) |

---

*See accompanying notes*

\| F-4 \|

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**](#)

**(Dollars in thousands)**

---

| | | |
|:---|:---|:---|
|  | **Year ended** <br>**December 31, 2025** | **Year ended** <br>**December 31, 2024** |
| &nbsp;&nbsp; **Common stock and paid-in capital**  |  |  |
| &nbsp;&nbsp; Balance, beginning of year  | $31696  | $46071  |
| &nbsp;&nbsp;Dividends paid |  | (14496) |
| &nbsp;&nbsp; Issuance of common stock for cash | 1000 |  |
| &nbsp;&nbsp; Issuance of common stock for convertible note | 3000 |  |
| &nbsp;&nbsp; Issuance of common stock for interest | 28 |  |
| &nbsp;&nbsp;Repurchase and cancellation of warrants | (33) |  |
| &nbsp;&nbsp; Share-based compensation expense  | 79  | 98  |
| &nbsp;&nbsp; Proceeds from employee stock purchase plan  | (1 ) | 23  |
| &nbsp;&nbsp; Balance, end of year  | $35769  | $31696  |
| &nbsp;&nbsp; **Accumulated other comprehensive loss**  |  |  |
| &nbsp;&nbsp; Balance, beginning of year  | $(306) | $(310 ) |
| &nbsp;&nbsp; Unrealized loss on available-for-sale securities, net of tax  |  | 17 |
| &nbsp;&nbsp; Foreign currency translation adjustment  | (34) | (13 ) |
| &nbsp;&nbsp; Balance, end of year  | $(340) | $(306 ) |
| &nbsp;&nbsp; **Accumulated deficit**  |  |  |
| &nbsp;&nbsp; Balance, beginning of year  | $(10059 ) | $(1076) |
| &nbsp;&nbsp; Net income (loss)  | (26084) | (8983) |
| &nbsp;&nbsp; Balance, end of year  | $(36143) | $(10059 ) |
| &nbsp;&nbsp; Total shareholders' equity  | $(714) | $21331  |

---

*See accompanying notes*

\| F-5 \|

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**CONSOLIDATED STATEMENTS OF CASH FLOWS**](#)

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,**  | **Year ended December 31,**  |
|  | **2025** | **2024** |
| Cash flows from operating activities:  |  |  |
| Net loss  | $(26084) | $(8983) |
| Adjustments to reconcile net loss to net cash used in operating activities:  |  |  |
| &nbsp;&nbsp;&nbsp; Amortization of right of use of assets  | 256  | 240 |
| &nbsp;&nbsp;&nbsp; Share-based compensation expense  | 79  | 98  |
| &nbsp;&nbsp;&nbsp; Non-cash interest expense | 28 |  |
| &nbsp;&nbsp;&nbsp;Loss on disposal of assets | 11143 |  |
| Changes in operating assets and liabilities:  |  |  |
| &nbsp;&nbsp;&nbsp; Inventories  | 39 |  |
| &nbsp;&nbsp;&nbsp; Accounts payable  | (46) | 44 |
| &nbsp;&nbsp;&nbsp; Accrued liabilities  | 289 | (41) |
| &nbsp;&nbsp;&nbsp; Operating lease liabilities  | (258) | (277) |
| Net cash used in operating activities | (14554) | (8919) |
| Cash flows from investing activities:  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from maturities and sales of marketable securities  | —  | 9724 |
| &nbsp;&nbsp;&nbsp; Purchases of marketable securities |  | (5229) |
| Net cash provided by investing activities |  | 4495 |
| Cash flows from financing activities:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividend payment |  | (14496) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from sale of stock | 1000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of convertible note | 3000 |  |
| &nbsp;&nbsp;&nbsp; Purchases of outstanding warrants | (33) |  |
| &nbsp;&nbsp;&nbsp; Proceeds from equity-based compensation programs  | (1) | 23  |
| Net cash provided by (used) in financing activities | 3966 | (14473) |
| Cash flows from discontinued operations |  |  |
| &nbsp;&nbsp;&nbsp; Net cash provided by operating activities | 7032 | 2497 |
| &nbsp;&nbsp;&nbsp; Net cash provided by investing activities | 2912 |  |
| &nbsp;&nbsp;&nbsp; Net cash provided by financing activities |  |  |
| Net cash provided by discontinued operations | 9944 | 2497 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | (34) | (18) |
| Net decrease in cash and cash equivalents and restricted cash | (678) | (16418) |
| Cash and cash equivalents and restricted cash at the beginning of the year | 1417 | 17835  |
| Cash and cash equivalents and restricted cash at the end of the year | $739 | $1417 |

---

\| F-6 \|

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

The following is a summary of supplemental cash flow information:

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,**  | **Year ended December 31,**  |
|  | **2025** | **2024** |
| Supplemental disclosure of cash flow information:  |  |  |
| Cash paid for income taxes  | $103  | $98  |
| Interest paid as non-cash dividend | 28 |  |
| Conversion of debt to Series B Preferred stock | 3026 |  |

---

*See accompanying notes*

\| F-7 \|

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**](#)

**(Dollars in thousands, except share and per share amounts)**

#### Note 1 - Business Description, Basis of Presentation and Significant Accounting Policies
***Business Description:***

ClearOne, Inc., together with its subsidiaries (collectively, "ClearOne" or the "Company"), was previously engaged in the design, development, and marketing of professional audio conferencing, microphone, and video collaboration solutions. On October 24, 2025, the Company completed the sale of a significant portion of its operating assets (the "Asset Sale"). Following the Asset Sale, the Company no longer manufactures or sells products and maintains a limited inventory and provides customer support services to satisfy warranty claims. Its continuing activities consist solely of fulfilling warranty and technical support obligations on legacy products, managing and liquidating remaining assets, collecting accounts receivable, satisfying outstanding liabilities, and maintaining public-company compliance. These activities are transitional in nature and are not expected to generate material revenue.

***Going Concern:***

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred significant losses, has negative cash flows from operations, and its continuing operations are limited and not expected to generate revenue at levels sufficient to fund ongoing costs. These conditions, together with the mandatory redemption obligation for the Class A Redeemable Preferred Stock (triggered by the closing of the Asset Sale on October 24, 2025), raise substantial doubt about the Company's ability to continue as a going concern within one year after the issuance date of these financial statements. Management is actively evaluating strategic alternatives intended to enhance stockholder value and improve liquidity. These alternatives may include one or more special transactions or other actions that maximize value for stockholders. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

***Basis of Presentation:***

The consolidated financial statements include the accounts of ClearOne, Inc. and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated. The financial statements are prepared in accordance with U.S. GAAP. The year ended December 31, 2025 includes the results of the disposed assets as discontinued operations that were sold on October 24, 2025. No allocation or smoothing of results between continuing and discontinued operations has been applied.

*Reverse Stock Split:* 

The Company completed a 1-for-15 reverse stock split of the Company's issued and outstanding common stock, par value $0.001 per share, effective at 5:00 p.m. Eastern Time on June 9, 2025. The common stock began trading on a split-adjusted basis on the Nasdaq Capital Market on June 10, 2025, under the symbol "CLRO" and a new CUSIP number of 18506U203. The reverse stock split was primarily intended to increase the per share market price of the common stock in order to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. As a result of the reverse stock split, every 15 shares of issued and outstanding common stock were automatically combined into one share, with no fractional shares issued (any fractional interests were rounded up to the next whole share). The reverse stock split did not change the par value of the common stock or the authorized number of shares but reduced the number of issued and outstanding shares from approximately 26.0 million to approximately 1.7 million, with proportional adjustments to outstanding stock options, warrants, and shares reserved under equity incentive plans. For additional details, refer to the Company's Current Report on Form 8-K filed with the SEC on June 2, 2025, including the press release attached as Exhibit 99.1 thereto.

All share and per-share amounts in these condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.

*Restricted Cash*consists of $519 in remaining proceeds from a $3,000 convertible note issued to First Finance Ltd. on June 20, 2025 (with no restricted cash balance as of March 31, 2025). These funds are subject to enforceable contractual restrictions per the disbursement schedule in Schedule 8.5 of the Note Purchase Agreement, which allocates proceeds to specific uses such as advisory fees, warrant holder payments, legal and audit expenses, staff costs (e.g., board fees, accounting staff, operations/sales staff bonuses), shutdown costs for foreign subsidiaries, and severance/PTO for employee layoffs. The funds are held in a segregated account and released only upon meeting specified milestones, with penalties for non-compliance.

\| F-8 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The Company includes restricted cash with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows, in accordance with ASU 2016-18. Restricted cash as of September 30, 2025, disbursed for severances, deal fees, legal fees, and compliance fees, resulting in the ending restricted cash balance. Full disbursement of the remaining restricted cash is expected by December 2025 as additional milestones are achieved. Restricted cash is classified as a current asset on the balance sheet and included in the total cash, cash equivalents, and restricted cash balances in the statement of cash flows. Changes in restricted cash are not presented as separate cash flows but are reconciled in this note. This classification and presentation provide transparency regarding the Company's liquidity, as the restricted funds are not available for general corporate purposes.

***Significant Accounting Policies:***

*Cash Equivalents* – The Company considers all highly-liquid investments with a maturity of three months or less, when purchased, to be cash equivalents. The Company places its temporary cash investments with high-quality financial institutions. At times, such investments may be in excess of the Federal Deposit Insurance Corporation insurance limits. As of December 31, 2025, there were no cash accounts in the United States that exceeded federally insured limits. In addition, there were foreign cash accounts in the amount of $46 that were not covered by Federal Deposit Insurance Corporation insurance.

*Marketable Securities -* The Company has classified its marketable securities as available-for-sale securities. These debt securities are carried at estimated fair value with unrealized holding gains and losses included in other comprehensive income (loss) in shareholders' equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned.

A decline in the market value of any available-for-sale security below cost that is deemed other than temporary results in a charge to earnings and establishes a new cost basis for the security. Losses are charged against "Other income" when a decline in fair value is determined to be other than temporary. We review several factors to determine whether a loss is other than temporary. These factors include, but are not limited to: (i) the extent to which the fair value is less than cost and the cause for the fair value decline, (ii) the financial condition and near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) our ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. There were no other-than-temporary impairments recognized during the years ended December 31, 2025 and 2024.

*Accounts Receivable* – Accounts receivable are recorded at the invoiced amount, net of expected returns and allowance for doubtful accounts. Generally, credit is granted to customers on a short-term basis without requiring collateral, and as such, these accounts receivable, do not bear interest, although a finance charge may be applied to such receivables that are past due. The Company extends credit to customers who it believes have the financial strength to pay. The Company has in place credit policies and procedures, an approval process for sales returns and credit memos, and processes for managing and monitoring channel inventory levels.

The allowance for credit losses is the Company's best estimate of the amount of probable credit losses in the Company's existing accounts receivable. Management regularly analyzes accounts receivable including current aging, historical write-off experience, customer concentrations, customer creditworthiness, and current economic trends when evaluating the adequacy of the allowance for doubtful accounts. We review customer accounts quarterly by first assessing accounts with aging over a specific duration and balance over a specific amount. We review all other balances on a pooled basis based on past collection experience. Accounts identified in our customer-level review as exceeding certain thresholds are assessed for potential allowance adjustment if we conclude the financial condition of that customer has deteriorated, adversely affecting their ability to make payments. Delinquent account balances are written off if the Company determines that the likelihood of collection is not probable. If the assumptions that are used to determine the allowance for credit losses change, the Company may have to provide for a greater level of expense in future periods or reverse amounts provided in prior periods.

\| F-9 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The Company's allowance for doubtful accounts activity for the years ended December 31, 2025 and 2024 is as follows (see Note 2, as accounts receivable and the allowance for doubtful accounts are included in current assets related to discontinued operations):

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2025** | **2024** |
| Balance at beginning of the year  | $405 | $326 |
| Allowance increase (decrease)  | (101) | 79 |
| Write offs, net of recoveries  |  |  |
| Balance at end of the year  | $304 | $405 |

---

*Inventories* – Inventories are valued at the lower of cost or market, with cost computed on a first-in, first-out ("FIFO") basis. In addition to the price of the product purchased, the cost of inventory includes the Company's internal manufacturing costs, including warehousing, engineering, material purchasing, quality and product planning expenses and applicable overhead, not in excess of estimated realizable value. Consideration is given to obsolescence, excessive levels, deterioration, direct selling expenses, and other factors in evaluating net realizable value.

The inventory includes advance replacement units (valued at cost) provided by the Company to end-users to service defective products under warranty. The value of advance replacement units included in the inventory was $353 and $392, as of December 31, 2025 and 2024, respectively.

*Property and Equipment* – Property and equipment are stated at cost less accumulated depreciation and amortization. Expenditures that materially increase values or capacities or extend useful lives of property and equipment are capitalized. Routine maintenance, repairs, and renewal costs are expensed as incurred. Gains or losses from the sale, trade-in, or retirement of property and equipment are recorded in current operations and the related book value of the property is removed from property and equipment accounts and the related accumulated depreciation and amortization accounts. Estimated useful lives are generally two to ten years. Depreciation and amortization are calculated over the estimated useful lives of the respective assets using the straight-line method. Leasehold improvement amortization is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the related assets.

*Intangible Assets –* Intangible assets are amortized over their useful lives unless these lives are determined to be indefinite. Intangible assets are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets, which are generally three to ten years. Intangible assets acquired in a purchase business combination and determined to have an indefinite useful life are not amortized.

*Impairment of Long-Lived Assets -* Long-lived assets, such as property, equipment, and definite-lived intangible assets subject to depreciation and amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated future undiscounted net cash flows of the related asset or group of assets over their remaining lives. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized for the amount by which the carrying amount exceeds the estimated fair value of the asset. Impairment of long-lived assets is assessed at the lowest levels for which there are identifiable cash flows that are independent of other groups of assets. The impairment of long-lived assets requires judgments and estimates. If circumstances change, such estimates could also change. Assets held for sale are reported at the lower of the carrying amount or fair value, less the estimated costs to sell.

\| F-10 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

*Leases:* We determine if an arrangement is a lease at inception. Operating leases are included in operating lease - right of use ("ROU") assets, accrued liabilities, and operating lease liability in our consolidated balance sheets. As of adoption of ASC 842 and as of December 31, 2025 and December 31, 2024, the Company was not party to finance lease arrangements. ROU assets represent our right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term. Under the available practical expedient, we account for the lease and non-lease components as a single lease component.

*Revenue Recognition Policy:* The Company generates revenue from sales of its audio and video conferencing equipment to distributors, system integrators and value-added resellers. The Company also generates revenue, to a much lesser extent, from sale of software and licenses to distributors, system integrators, value-added resellers and end-users. The Company recognizes revenue when it satisfies a performance obligation in an amount reflecting the consideration to which it expects to be entitled. For sales agreements, the Company has identified the promise to transfer products, each of which are distinct, to be the performance obligation. The Company applies a five-step approach in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer, (2) identifying the performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations in the contract and (5) recognizing revenue when the performance obligation is satisfied. Substantially all of the Company's revenue is recognized at the time control of the products transfers to the customer.

Sales agreements with customers are renewable periodically and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require mandatory purchase commitments. In the absence of a sales agreement, the Company's standard terms and conditions at the time of acceptance of purchase orders apply. The Company considers the customer purchase orders, governed by sales agreements or the Company's standard terms and conditions, to be the contract with the customer. The Company evaluates certain factors including the customer's ability to pay (or credit risk)

In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Sales to distributors, are typically made pursuant to agreements that provide return rights with respect to discontinued or slow-moving products, referred to as stock rotation. Sales to distributors can also be subject to price adjustment on certain products, primarily for distributors with drop-shipping rights. Although payment terms vary, most distributor agreements require payment within 45 days of invoicing.

The Company recognizes revenue when it satisfies a performance obligation. The Company recognizes revenue from sales agreements upon transferring control of a product to the customer. This typically occurs when products are shipped or delivered, depending on the delivery terms, or when products that are consigned at customer locations are sold to dealers or end users. Sales returns and allowances are estimated based on historical experience. Provisions for discounts and rebates to customers, estimated returns and allowances, ship and credit claims and other adjustments are provided for in the same period the related revenues are recognized, and are netted against revenues. For returns, the Company recognizes a related asset for the right to recover returned products with a corresponding reduction to cost of goods sold. The Company reviews warranty and related claims activity and records provisions, as necessary.

Frequently, the Company receives orders with multiple delivery dates that may extend across reporting periods. Since each delivery constitutes a performance obligation, the Company allocates the transaction price of the contract to each performance obligation based on the stand-alone selling price of the products. The Company invoices the customer for each delivery upon shipment and recognizes revenues in accordance with delivery terms. Although payment terms vary, distributors typically pay within 45 days of invoicing and dealers pay within 30 days of invoicing. As scheduled delivery dates are within one year, revenue allocated to future shipments of partially completed contracts are not disclosed.

The Company has elected to record freight and handling costs associated with outbound freight after control over a product has transferred to a customer as a fulfillment cost and include it in cost of revenues. Taxes assessed by government authorities on revenue-producing transactions, including value-added and excise taxes, are presented on a net basis (excluded from revenues) in the consolidated statements of operations and comprehensive income (loss).

\| F-11 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The details of deferred revenue and associated cost of goods sold and gross profit are as follows:

---

| | | |
|:---|:---|:---|
|  | **As of December 31,** | **As of December 31,** |
|  | **2025** | **2024** |
| Deferred revenue  | $— | $17 |
| Deferred cost of goods sold  |  |  |
| Deferred gross profit  | $— | $17 |

---

The Company offers rebates and market development funds to certain of its distributors, dealers/resellers, and end-users based upon the volume of product purchased by them. The Company records rebates as a reduction of revenue in accordance with GAAP.

The Company provides, at its discretion, advance replacement units to end-users on defective units of certain products under warranty. Since the purpose of these units is not revenue generating, the Company tracks the units due from the end-user, until the defective unit has been returned. Any amount due from the customer upon failure to return the products is accounted as receivable only after establishing customer's failure to return the products. The inventory due from the customer is accounted at cost or market value whichever is lower.

The following table disaggregates the Company's revenue into primary product groups (see Note 2, as all revenue is classified in discontinued operations):

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2025** | **2024** |
| Audio Conferencing  | $2187  | $4287  |
| Microphones  | 3017  | 5195  |
| Video products  | 805  | 1904  |
|  | $6009  | $11386  |

---

The following table disaggregates the Company's revenue into major regions:

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2025** | **2024** |
| North and South America  | $3613 | $4178 |
| Asia (including Middle East) and Australia  | 1458 | 5959 |
| Europe and Africa  | 938 | 1249 |
|  | $6009 | $11386 |

---

*Warranty Costs* – The Company accrues for warranty costs based on estimated warranty return rates and estimated costs to repair. These reserve costs are classified as accrued liabilities on the consolidated balance sheets. Factors that affect the Company's warranty liability include the number of units sold, historical and anticipated rates of warranty returns, and repair cost. The Company reviews the adequacy of its recorded warranty accrual on a quarterly basis.

The details of changes in the Company's warranty accrual are as follows:

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2025** | **2024** |
| Balance at the beginning of year  | $194 | $194 |
| &nbsp;&nbsp;&nbsp; Accruals/additions  | 167 |  |
| &nbsp;&nbsp;&nbsp; Usage/claims  |  |  |
| Balance at end of year  | $361 | $194 |

---

\| F-12 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

*Advertising* – The Company expenses advertising costs as incurred. Advertising costs consist of trade shows, magazine advertisements, and other forms of media. Advertising expenses for the years ended December 31, 2025 and 2024 totaled $227 and $526, respectively, and are included in discontinued operations on the consolidated statements of operations and comprehensive income (loss).

*Income Taxes* – The Company uses the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carry-forwards. These temporary differences will result in deductible or taxable amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided when it is more likely than not that some or all of the deferred tax assets may not be realized. On a quarterly basis, the Company tests the value of deferred tax assets for impairment at the taxpaying-component level within each tax jurisdiction. Significant judgment and estimates are required in determining whether valuation allowances should be established as well as the amount of such allowances.

The valuation allowance is based on our estimates of future taxable income and the period over which we expect the deferred tax assets to be recovered. Our assessment of future taxable income is based on historical experience and current and anticipated market and economic conditions and trends. In 2018, as a result of negative evidence, principally three years of cumulative pre-tax operating losses, we concluded that it was more likely than not that net operating losses, tax credits and other deferred tax assets were not realizable and therefore, we recorded a full valuation allowance against those net deferred tax assets. We continue to record full valuation against our net deferred tax assets. Adjustments to the valuation allowance increase or decrease the Company's income tax provision or benefit.

As of December 31, 2025 the Company had no net deferred tax assets due to valuation allowances recorded to account for the consecutive quarters with losses before taxes.

*Recent changes:* There were no changes that had a material impact on the Company's consolidated financial position, results of operations or cash flows.

*Earnings Per Share* – The following table sets forth the computation of basic and diluted loss per common share:

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2025** | **2024** |
| Numerator:  |  |  |
| &nbsp;&nbsp;&nbsp; Loss from continuing operations  | $(4624) | $(1850) |
| &nbsp;&nbsp;&nbsp; Loss from discontinued operations | (21460) | (7133) |
| &nbsp;&nbsp;&nbsp;Interest adjustment under if-converted method |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Adjusted net income | (26084) | (8983) |
| Denominator:  |  |  |
| &nbsp;&nbsp;&nbsp; Basic weighted average shares  | 1765654 | 1598756 |
| &nbsp;&nbsp;&nbsp; Dilutive common stock equivalents using if-converted method  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diluted weighted average shares  | 1765654 | 1598756 |
| Basic income (loss) per common share: |  |  |
| &nbsp;&nbsp;&nbsp; From continuing operations | $(2.62) | $(1.19) |
| &nbsp;&nbsp;&nbsp; From discontinued operations | (12.15) | $(4.42) |
| Total | (14.77) | $(5.61) |
| Diluted income (loss) per common share: |  |  |
| &nbsp;&nbsp;&nbsp; From continuing operations | $(2.62) | $(1.19) |
| &nbsp;&nbsp;&nbsp; From discontinued operations | (12.15) | $(4.42) |
| Total | (14.77) | $(5.61) |
| Weighted average options, warrants and convertibles outstanding  | 576145 | 370254 |
| Anti-dilutive options and warrants not included in the computation  | 576145 | 370254 |

---

\| F-13 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

*Share-Based Payment* – We estimate the fair value of stock options using the Black-Scholes option-pricing model, which requires certain estimates, including an expected forfeiture rate and expected term of options granted. We also make decisions regarding the method of calculating expected volatilities and the risk-free interest rate used in the option-pricing model. The resulting calculated fair value of stock options is recognized as compensation expense over the requisite service period, which is generally the vesting period. When there are changes to the assumptions used in the option-pricing model, including fluctuations in the market price of our common stock, there will be variations in the calculated fair value of our future stock option awards, which results in variation in the compensation cost recognized.

*Operating Segment* – The Company operates as one operating segment. Operating segments are defined as components of an entity for which separate financial information is regularly evaluated by the chief operating decision maker ("CODM"), which is the Company's Chief Executive Officer, in deciding how to allocate resources and assess performance. The Company's CODM evaluates financial information and resources and assesses the performance of these resources on a consolidated basis. There is no expense or asset information that is supplemental to information disclosed within the consolidated financial statements, that is regularly provided to the CODM. The allocation of resources and assessment of performance of the operating segment is based on consolidated net loss and functional expenses as reported on our consolidated statements of operations and comprehensive loss. Because the Company operates as one operating segment, financial segment information, including expense and asset information, can be found in the consolidated financial statements.

*Recently issued accounting pronouncements:*

*ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures*

In November 2023, the FASB issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The standard is effective for full year 2024 reporting, and for interim reporting beginning in 2025. The adoption of this ASU did not change the way the Company evaluates its reportable segments and, as a result, did not have a material impact on the Company's segment-related disclosures.

*ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures*

In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." This update enhances income tax disclosure requirements, primarily by requiring greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disclosures. For public business entities, such as the Company, ASU 2023-09 mandates a tabular reconciliation of the effective tax rate using both percentages and reporting currency amounts, with specific categories of reconciling items and additional detail for items meeting a quantitative threshold of 5% of the expected tax amount. Additionally, the standard requires annual disclosure of income taxes paid, disaggregated by federal, state, and foreign jurisdictions, with further breakout by individual jurisdiction if the amount is significant. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted, and should be applied prospectively, though retrospective application is optional. The Company adopted the new standard on January 1, 2025, using the retrospective transition method. The adoption modified the presentation of our income tax disclosures (see Note 14) but did not have a material impact on our consolidated financial position or results of operations.

*ASU 2024-03, Income Statement—Reporting Comprehensive Income (Topic 220): Disaggregation of Income Statement Expenses*

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income (Topic 220): Disaggregation of Income Statement Expenses," which requires public business entities, such as the Company, to provide disaggregated disclosure of specific natural expense categories underlying certain income statement expense line items in the notes to the financial statements. The standard identifies five required natural expense categories for disaggregation—employee compensation, depreciation, amortization, inventory expense, and other manufacturing expenses—along with a residual "other" category for remaining amounts within relevant expense captions (e.g., cost of sales, selling, general and administrative expenses). ASU 2024-03 does not alter the expense captions presented on the face of the income statement but enhances footnote disclosures to improve transparency. The standard is effective for annual periods beginning after December 15, 2026, with early adoption permitted, and must be applied prospectively, though retrospective application is optional. An update in ASU 2025-01 clarified that interim period disclosures are not required until annual periods beginning after December 15, 2027. The Company is currently developing its implementation plan and evaluating the impact of this standard on its consolidated financial statement disclosures. While we expect adoption to necessitate modifications to our financial reporting processes and systems to capture the required disaggregated information, management does not expect a material effect on our reported financial position or results of operations.

\| F-14 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

**Discontinued Operations:**

See Note 2 for a full description of the Asset Sale and presentation of discontinued operations.

***Use of Estimates:***

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts. Key estimates include valuation of retained warranty inventory, warranty reserves, legal contingencies, and the going-concern assessment. Actual results could differ materially from these estimates.

**Note 2 – Discontinued Operations and Asset Sale** 

On October 24, 2025, the Company completed the sale of substantially all of its operating intellectual property, product inventory, and related production assets to Biamp Systems, LLC ("Biamp") for gross cash consideration of $3,000 (the "Asset Sale"). Biamp did not assume any warranty or technical support obligations. The Company retained its books and records, all equity interests in subsidiaries, approximately $390 of inventory solely to service warranty obligations, and all public-company assets and obligations. See the Company's Current Report on Form 8-K filed October 30, 2025 for additional information.

The sale represents the disposal of a component that qualifies as discontinued operations under ASC 205-20. The results of the disposed assets are presented as discontinued operations for all periods presented, with a hard cutoff on the legal closing date of October 24, 2025. No allocation or smoothing of results has been applied.

At September 30, 2025, the disposal group was classified as held for sale and measured at fair value less costs to sell. The carrying amount of the disposal group was $13,641 (primarily inventory of $12,856 and intangible assets of $785). Based on the executed asset purchase agreement for $3,000 cash consideration and estimated transaction costs of $100, management recorded an impairment of $10,741 to reduce the disposal group to fair value less costs to sell. The impairment is included in "Loss from discontinued operations" in the consolidated statements of operations.

*Carrying amounts classified as held for sale* 

* Assets held for sale at September 30, 2025 totaled $2,900 (comprised primarily of inventory $12,956 and intangibles $785, less impairment to fair value less costs to sell of $10,741 and transaction costs of $100).

* Liabilities held for sale at September 30, 2025 were $0 (no obligations transferred).

The carrying value of net assets sold at the October 24, 2025 closing date, after the Q3 impairment and additional changes in October, was $14,055. The loss on sale recognized in the fourth quarter of 2025 was calculated as follows (in thousands):

---

| | |
|:---|:---|
|  | **Amount** |
| **Description**  |  |
| Gross proceeds from Asset Sale | $3000 |
| Less: Transaction costs | (88) |
| Less: Carrying value of net assets sold (after impairment) | (14055) |
| **Loss on sale** | $(11143) |

---

\| F-15 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The major classes of assets and liabilities of the disposed assets as of the October 24, 2025 closing date (gross carrying value before impairment allocation) were as follows (in thousands):

---

| | |
|:---|:---|
| **Assets** | **Amount** |
| Inventories, net | $**16114** |
| Property and equipment, net | 518 |
| Intangible assets, net | 1568 |
| Other assets | 3127 |
| **Total assets disposed** | $21327 |

---

---

| | |
|:---|:---|
| **Liabilities** | **Amount** |
| Accounts payable and accrued liabilities | $2588 |
| Other liabilities | 1101 |
| Total liabilities disposed | 3689 |
| **Net assets disposed** | $17638 |

---

The difference between the gross carrying value of $17,638 and the post-impairment carrying value of $14,055 used in the loss on sale calculation is attributable to the Q3 impairment of $10,741 and additional net asset activity in October 2025.

The results of discontinued operations for the years ended December 31, 2025 and 2024 are summarized as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31, 2025** | **Year Ended December 31, 2024**  |
| **Revenue** | $6009 | $11386 |
| Cost of goods sold | 9030 | 8563 |
| Gross profit (loss) | (3021) | 2823 |
| Operating expenses | 7296 | 9899 |
| Operating loss | (10317) | (7076) |
| Loss on sale | (11143) |  |
| Loss before income taxes | (21460) | (7076) |
| Income tax benefit (provision)  |  |  |
| **Loss from discontinued operations, net of tax** | $(21460) | $(7076) |

---

Following the Asset Sale, the Company continues to fulfill warranty and technical support obligations on products sold October 24, 2025 in accordance with published policies. The Company retained a limited amount of inventory solely to service these obligations. These activities are reported within continuing operations and do not constitute ongoing operations of the disposed assets.

Cash flows from discontinued operations are included in the consolidated statements of cash flows. For the year ended December 31, 2025, net cash provided by discontinued operations was $9,944.

Net proceeds from the Asset Sale are contractually earmarked to redeem the Class A Redeemable Preferred Stock. Redemption occurred after December 31, 2025 and is treated as a subsequent event.

\| F-16 \|

------

[**Table of Contents**](#TOC)

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Dollars in thousands, except share and per share amounts)**

**Note 3 - Marketable Securities**

All marketable securities were liquidated during 2025 to support working capital needs. There were no marketable securities as of December 31, 2025 or 2024.

**Note 4 - Intangible Assets**

All intangible assets were sold as part of the Asset Sale on October 24, 2025. There were no intangible assets remaining as of December 31, 2025

**Note 5 - Inventories**

Inventories consist solely of the limited amount retained to service warranty obligations:

---

| | | |
|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2024** |
| Current (warranty servicing) | $353 | $392 |
| Total | $353 | $392 |

---

**Note 6 - Property and Equipment**

All property and equipment associated with the disposed operations were sold as part of the Asset Sale. All remaining property and equipment consist primarily of office supplies and aged computer equipment which was written off as de minumus:

---

| | | |
|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2024** |
| Office furniture and equipment  | $—  | $68  |
| Leasehold improvements  | $—  | $205  |
| Warehouse equipment  | $—  | $227  |
| Total | $—  | $500  |
| Accumulated depreciation | $— | $— |
| Property and equipment, net  | $—  | $500  |

---

Depreciation expense included in discontinued operations totaled$232 thousand and $226 thousand for the years ended December 31, 2025 and 2024 respectively.No depreciation expense was recorded in continuing operations for either period.

\| F-17 \|

------

[**Table of Contents**](#TOC)

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Dollars in thousands, except share and per share amounts)**

**Note 7 - Leases**

Rent expense is recognized on a straight-line basis over the period of the lease considering future rent escalation and holiday periods.

Rent expense for the years ended December 31, 2025 and 2024 was as follows:

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,** | **Year ended December 31,** |
|  | **2025** | **2024** |
| Rent expense | $300 | $460 |

---

We occupy approximately 9,402 square feet of office space in Salt Lake City, Utah under an operating lease expiring in February 2028. This facility supports the Company's remaining administrative functions, public company compliance activities, and limited operational support functions.

The Company previously occupied a 1,350 square-foot facility in Gainesville, Florida under an operating lease that had been extended to February 29, 2029. On March 2, 2026, the Company entered into a Settlement, Release and Agreement to Terminate Lease with the landlord. Pursuant to the settlement, the Company paid $30 and forfeited its security deposit in exchange for full termination of the lease and a mutual release of all obligations. The Company has no further liability under this lease.

The Company previously occupied a 2,590 square-foot warehouse facility in Salt Lake City, Utah (363 West 2720 South, Suite B) under an operating lease scheduled to expire in February 2028. On February 24, 2026, the Company entered into an Early Termination Agreement with the landlord that terminated the lease effective midnight February 28, 2026. In connection with the early termination, the Company paid a buyout of $43 and forfeited its security deposit. The Company has no further liability under this lease after February 28, 2026. This facility previously supported warranty servicing and repair activities related to products sold prior to the October 2025 asset disposition.

The Company previously occupied a 6,175 square-foot facility in Chennai, India under the terms of an operating lease which expired September 2025. This facility supported our administrative, marketing, customer support, and research and product development activities. We did not renew the lease and vacated these premises on November 15, 2025 and the deposit was refunded in January 2026.

Supplemental cash flow information related to leases was as follows:

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,** | **Year ended December 31,** |
|  | **2025** | **2024** |
| Cash paid for amounts included in the measurement of lease liabilities:  |  |  |
| &nbsp;&nbsp;&nbsp; Operating cash flows from operating leases  | $300 | $462 |
| Right-of-use assets obtained in exchange for lease obligations:  |  |  |
| &nbsp;&nbsp;&nbsp; Operating leases  | $256 | $175 |

---

Supplemental balance sheet information related to leases was as follows:&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2024** |
| Operating lease right-of-use assets  | $494 | $750 |
| Current portion of operating lease liabilities, included in accrued liabilities  | $223 | $257 |
| Operating lease liabilities, net of current portion  | 290 | 514 |
| &nbsp;&nbsp;&nbsp; Total operating lease liabilities  | $513 | $771 |
| Weighted average remaining lease term for operating leases (in years)  | 2.17 | 2.99 |
| Weighted average discount rate for operating leases  | 6.76% | 6.59% |

---

\| F-18 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The following represents maturities of operating lease liabilities as of December 31, 2025:

---

| | |
|:---|:---|
| **Years ending December 31,** |  |
| &nbsp;&nbsp;&nbsp; 2026 | $223 |
| &nbsp;&nbsp;&nbsp; 2027 | 247 |
| &nbsp;&nbsp;&nbsp; 2028 | 43 |
| &nbsp;&nbsp;&nbsp; 2029 |  |
| &nbsp;&nbsp;&nbsp; 2030 |  |
| &nbsp;&nbsp;Thereafter |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total lease payments | 513 |
| &nbsp;&nbsp;&nbsp; Less: Imputed interest |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $513 |

---

Subsequent Events

Subsequent to December 31, 2025, the Company terminated two of its operating leases: (i) the Gainesville, Florida facility was terminated on March 2, 2026 via a settlement agreement with a $30 cash payment and forfeiture of the security deposit; and (ii) the Salt Lake City warehouse facility was terminated effective February 28, 2026 via an early termination agreement with a $43 buyout and forfeiture of the security deposit. The Company has no further liability under either lease. See Note 17 – Subsequent Events for additional information.

**Note 8 - Accrued Liabilities**

Accrued liabilities consist of the following:

---

| | | |
|:---|:---|:---|
|  | **As of December 31,**  | **As of December 31,**  |
|  | **2025** | **2024** |
| Accrued salaries and other compensation  | $104 | $30  |
| Warranty reserve  | 361 | 194  |
| Severance obligation<br>| 71 | —  |
| Other accrued liabilities  | 113 | 136  |
| &nbsp;&nbsp;&nbsp; Total  | $649 | $360  |

---

Note 9 - Commitments and Contingencies

*Legal Proceedings*

See Item 3 – Legal Proceedings for incorporation by reference.

*Spain Employee Settlement*

ClearOne Spain, S.L. ("ClearOne Spain"), a wholly owned subsidiary, entered into a binding settlement agreement with eight former employees to resolve wrongful termination and severance claims arising from a collective dismissal implemented in August 2025.

* The settlement agreement was executed on December 29, 2025.

* The Board of Directors of ClearOne, Inc. approved the settlement on December 31, 2025.

* The agreement fixed the Company's obligation to pay net settlement proceeds of €393 (€362 compensation + €31 severance).

Management concluded the obligation was both probable and reasonably estimable as of December 31, 2025 under ASC 450-20 and therefore accrued the full amount at year-end. The USD equivalent recorded at the December 31, 2025 spot rate was $461. Due to ClearOne Spain being part of the discontinued operations, this accrual is included in current liabilities related to discontinued operations on the balance sheet.

Payment of the settlement was made on January 14, 2026 (value date January 16, 2026) and the formal ratification occurred at the Zaragoza SMAC conciliation hearing on January 21, 2026. These events are treated as non-recognized subsequent events with respect to cash disbursement timing only. No adjustment to the year-end accrual was required.

\| F-19 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The settlement is disclosed in the Discontinued Operations footnote (Note 2) to the extent it relates to the disposed business, as well as in Subsequent Events (Note 17) and Legal Proceedings (Item 3).

*Executive Retention Bonuses*

In connection with post-transaction leadership restructuring, the Company granted retention bonuses to Derek Graham and Simon Brewer contingent upon the completion of certain projects and duration of employment and the closing of a future transaction of the Company, respectively. These bonuses are not probable or estimable as of December 31, 2025 and are therefore disclosed only.

*Other Contingencies*

The Company is involved from time to time in claims and legal proceedings arising in the ordinary course of business. Management does not believe any such matters will have a material adverse effect on the Company's financial position, results of operations, or cash flows.

**Note 10 - Debt**

On July 21, 2025, the Company's $3.0 million convertible note issued on June 20, 2025 to First Finance Ltd. (together with $26 of accrued interest) automatically converted into 3,026 shares of Class B Convertible Preferred Stock pursuant to its original terms. The conversion ratio of 166.44474 common shares per Class B share was determined at issuance based on the Nasdaq closing price and 5-day average closing prices on June 19, 2025 (the trading day immediately preceding execution of the note and purchase agreement) and is fixed (subject only to customary anti-dilution). Because the conversion option is indexed to, and will be settled in, the Company's own equity, it qualifies for the ASC 815-40 "own-equity" scope exception; accordingly, no derivative liability was recorded and the full conversion amount was recognized in equity, with no gain or loss recognized on conversion. The Company has 5,100 Class B shares authorized and 3,026 issued and outstanding as of September 30, 2025. This conversion represents a non-cash financing activity and is disclosed in the supplemental cash flow information. Class B Convertible Preferred Stock is convertible into common stock in accordance with its Certificate of Designation filed as Exhibit 3.2 to the Company's Current Report on Form 8-K as filed with the SEC on June 25, 2025. There was no debt outstanding as of December 31, 2025 or 2024.On November 24, 2025, First Finance Ltd. converted all 3,026 shares of Class B Convertible Preferred Stock into 503,662 shares of common stock at the fixed conversion price of $6.008 per share. This non-cash conversion is reflected in the consolidated financial statements as of December 31, 2025, with no Class B Convertible Preferred Stock remaining outstanding.

**Note 11 - Share-Based Payments**

*<u>Employee Stock Option Plans</u>*

The Company's share-based incentive plan offering stock options is primarily through 2007 Equity Incentive Plan (the "2007 Plan"). Under this plan, one new share is issued for each stock option exercised. The plan is described below.

The 2007 Plan was restated and approved by the shareholders on December 12, 2016. Provisions of the restated 2007 Plan include the granting of up to 2,000,000 incentive and non-qualified stock options, stock appreciation rights, restricted stock and restricted stock units. Options may be granted to employees, officers, non-employee directors and other service providers and may be granted upon such terms as the Compensation Committee of the Board of Directors determines in their sole discretion.

Generally vesting schedules for options granted are based on 3 or 4-year vesting schedules, with either one-third or one-fourth vesting on the first anniversary and the remaining options vesting ratably over the remainder of the vesting term. Generally, directors and officers have 3-year vesting schedules and all other employees have 4-year vesting schedules. Additionally, in the event of a change in control or the occurrence of a corporate transaction, the Company's Board of Directors has the authority to elect that all unvested options shall vest and become exercisable immediately prior to the event or closing of the transaction. As of December 31, 2025, the Company had 2,769 options with contractual lives of ten years and 16,947 options with contractual lives of six years.

As of December 31, 2025, there were 19,716 options outstanding under the 2007 Plan. As of December 31, 2025, the 2007 Plan had 1,980,284 authorized unissued options.

The Company uses judgment in determining the fair value of the share-based payments on the date of grant using an option-pricing model with assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the risk-free interest rate of the awards, the expected life of the awards, the expected volatility over the term of the awards, and the expected dividends of the awards. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based payments granted under the guidelines of ASC Topic 718.

\| F-20 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

In applying the Black-Scholes methodology to the 10,667 options granted during the year ended December 31, 2024, the Company used the following assumptions:

---

| | |
|:---|:---|
| Risk free interest rate, average | 4.06% |
| Expected option life, average | 3.5 years |
| Expected price volatility, average | 107.23% |
| Expected dividend yield | 0.00% |

---

There were no options granted during the year ended December 31, 2025.

The risk-free interest rate is determined using the U.S. Treasury rate in effect as of the date of the grant, based on the expected life of the stock option. The expected life of the stock option is determined using historical data.

The expected price volatility is determined using a weighted average of daily historical volatility of the Company's stock price over the corresponding expected option life.

Under guidelines of ASC Topic 718, the Company recognizes the associated compensation cost for only those awards expected to vest on a straight-line basis over the underlying requisite service period. The Company estimated the forfeiture rates based on its historical experience and expectations about future forfeitures.

The following table shows the stock option activity:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of Shares**  | **Weighted Average Exercise Price**  | **Weighted Average Remaining Contractual Term (Years)**  | **Aggregate Intrinsic Value**  |
| As of December 31, 2023 | 40521 | $75.45 | 3.32 |  |
| &nbsp;&nbsp;&nbsp;Granted | 10667 | 7.35 |  |  |
| &nbsp;&nbsp;&nbsp;Expired and canceled | (10787) | 98.10 |  |  |
| &nbsp;&nbsp;&nbsp;Forfeited prior to vesting | (2445) | 76.35 |  |  |
| &nbsp;&nbsp;&nbsp;Exercised |  |  |  |  |
| As of December 31, 2024  | 37956 | $49.76  | 3.54  | $— |
| &nbsp;&nbsp;&nbsp; Granted  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Expired and canceled  | (15016) | 78.42  |  |  |
| &nbsp;&nbsp;&nbsp; Forfeited prior to vesting  | (3224) | 15.15  |  |  |
| &nbsp;&nbsp;&nbsp; Exercised  |  |  |  |  |
| As of December 31, 2025  | 19716  | $35.33  | 3.44  | $— |
| Vested and Expected to Vest at December 31, 2024  | 37956  | $49.76  | 3.54  | $— |
| Vested at December 31, 2024  | 23331  | $79.35  | 2.15  | $— |
| Vested and Expected to Vest at December 31, 2025  | 19716  | $35.33  | 3.44  | $— |
| Vested at December 31, 2025  | 19716  | $35.33  | 3.44  | $— |

---

\| F-21 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The total pre-tax compensation cost related to stock options recognized during the years ended December 31, 2025 and 2024 was $78 and $89, respectively. Tax benefit from compensation cost related to stock options during the years ended December 31, 2025 and 2024, respectively was $1 and $2. As of December 31, 2025, the total compensation cost related to stock options not yet recognized and before the effect of any forfeitures was $0, which is expected to be recognized over approximately the next 0.0 years on a straight-line basis.

*<u>Employee Stock Purchase Plan</u>*

During the years ended December 31, 2025 and 2024, the Company maintained a 2016 Employee Stock Purchase Plan (the "ESPP"). The ESPP was approved by the Company's shareholders on December 12, 2016. Offering periods under the ESPP commenced on each January 1 and July 1 and continued for a duration of six months. The ESPP was available to all employees who did not own, or were deemed to own, shares of stock making up an excess of 0% of the combined voting power of the Company, its parent or subsidiary.

In connection with the significant reduction in force completed in June 2025, the Company terminated the ESPP effective July 2025. All participant contributions were refunded to employees in May and June 2025, totaling approximately $1. No shares were issued under the ESPP during the year ended December 31, 2025.

Shares purchased and compensation expense associated with the ESPP were as follows:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Shares purchased under ESPP plan  | —  | 2775  |
| Plan compensation expense  | $—  | $6  |

---

As of December 31, 2025, the ESPP has been terminated and no shares remain available for future issuance.

*<u>Issuance of Common Stock and Warrants</u>*

On September 13, 2020, the Company, entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain purchasers named therein (the "Purchasers"), pursuant to which the Company issued and sold, in a registered direct offering 141,070 shares (the "Shares") of the Company's common stock, par value $0.001 per share (the "Common Stock") at an offering price of $37.39 per share, (the "Registered Offering"). The Company received gross proceeds of approximately $5,275 (4,764 net of issuance costs) in connection with the Registered Offering, before deducting placement agent fees and related offering expenses. In a concurrent private placement, the Company issued to the Purchasers who participated in the Registered Offering warrants exercisable for an aggregate of 70,535 shares of common stock at an exercise price of $36.45 per share. Each warrant became immediately exercisable and had an expiry term of five years from the issuance date.

On September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 241,546 shares of the Company's common stock, par value $0.001 per share at an offering price of $41.40 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 241,546 shares of common stock at an exercise price of $39.60 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.

*Warrants Repurchased (and Related Party)*

During September 2025, the Company repurchased and cancelled outstanding warrants from (i) Intracoastal Capital, LLC (6,039 underlying shares) on September 2, 2025 for an aggregate purchase price of $4, (ii) Lind Global Fund II, LP (24,155 underlying shares) on September 10, 2025 for $15, (iii) Edward Dallin Bagley (related party; 18,940 underlying shares) on September 17, 2025 for $12, and (iv) Edward Bryan Bagley (3,788 underlying shares) on September 16, 2025 for $2. The repurchased warrants were cancelled upon settlement and accounted for as equity transactions with no effect on the statement of operations. As of September 30, 2025, warrants to purchase an aggregate of 218,887 shares of common stock remained outstanding. The Company did not issue new warrants during the quarter.

The repurchase price and other terms of the warrants repurchase from Edward Dallin Bagley were approved by the Board of Directors in accordance with the Company's policy regarding related person transactions. No amounts were outstanding with Mr. Bagley related to these warrants as of September 30, 2025.

Subsequent to December 31, 2025, the Company repurchased and cancelled 24,155 of the September 12, 2021 warrants (see Note 17 – Subsequent Events).

\| F-22 \|

------

[**Table of Contents**](#TOC)

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Dollars in thousands, except share and per share amounts)**

**Note 12 - Significant Customers**

The following customer concentration information relates to the discontinued operations for the periods presented.

During the year ended December 31, 2025, three of our distributors accounted for 10% or more of total sales. Customer A accounted for 12%, Customer B accounted for 13%, and Customer C accounted for 10%. For the year ended December 31, 2024, one distributor, customer D, accounted for more than 17% of our total consolidated revenue. As of December 31, 2025, customer E accounted for 16%, customer A accounted for 13%, customer F accounted for 11%, customer G accounted for 11%, and customer H accounted for 11% of trade accounts receivable. As of December 31, 2024, customer D accounted for 30% and customer A accounted for 12% of trade accounts receivable.

**Note 13 - Fair Value Measurements**

The fair value of the Company's financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:

<u>Level 1</u> - Quoted prices in active markets for identical assets and liabilities.

<u>Level 2</u> - Observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. This category generally includes U.S. Government and agency securities; municipal securities; mutual funds and securities sold and not yet settled.

<u>Level 3</u> - Unobservable inputs.

As of December 31, 2025 the Company had no financial instruments requiring fair value measurement under the three-level hierarchy.

**Note 14 - Income Taxes**

Consolidated income (loss) before income taxes, continuing operations, for domestic and foreign operations consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,**  | **Year ended December 31,**  |
|  | **2025** | **2024** |
| Domestic  | $(4541) | $(1752) |
| Foreign  |  |  |
| Total  | $(4541) | $(1752) |

---

\| F-23 \|

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

The Company's provision for income taxes, continuing operations, consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,**  | **Year ended December 31,**  |
|  | **2025** | **2024** |
| Current:  |  |  |
| &nbsp;&nbsp;&nbsp; Federal  | $(79) | $(76) |
| &nbsp;&nbsp;&nbsp; State  | (4) | (22) |
| &nbsp;&nbsp;&nbsp; Foreign  |  |  |
| Total current  | (83) | (98) |
| Deferred:  |  |  |
| &nbsp;&nbsp;&nbsp; Federal  | 7287 | 1745 |
| &nbsp;&nbsp;&nbsp; State  | 1273 | 275 |
| &nbsp;&nbsp;&nbsp; Foreign  | —  | —  |
| &nbsp;&nbsp;&nbsp; Total  | 8560 | 2020 |
| Change in valuation allowance  | (8560) | (2020) |
| Total deferred  | —  |  |
| Tax provision  | $(83) | $(98) |

---

In accordance with the retrospective adoption of ASU 2023-09, the following table provides a tabular reconciliation of the income tax provision for continuing operations compared to the federal statutory rate for the years ended December 31, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Year ended December 31,** | **Year ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
|  | **2025** |  | **2024** |  |
| U.S. federal statutory income tax rate at 21.0 %  | $(955) | 21.0% | $(368) | 21.0% |
| 1. State and local income tax, net of federal (national) income tax effect  | 4 | (0.1)% | 22 | (1.3)% |
| 2. Foreign tax effects  | —  | 0.0% | —  | 0.0% |
| 3. Effect of changes in tax laws or rates enacted in the current period  |  | 0.0% |  | 0.0% |
| 4. Effect of cross-border tax laws |  | 0.0% |  | 0.0% |
| 5. Tax credits - R&D  |  | 0.0% | (49) | 2.8% |
| 6. Changes in valuation allowances  | 876 | (19.3)% | 327 | (18.6)% |
| 7. Nontaxable or nondeductible items  | 97 | (2.1)% | 112 | (6.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Intercompany Loan Interest  | 80 | (1.8)% | 88 | (5.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Stock-based Compensation | 16 | (0.3)% | 18 | (1.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Nontaxable or nondeductible items - Other | 1 | 0.0% | 6 | (0.3)% |
| 8. Changes in unrecognized tax benefits  | 61 | (1.4)% | 54 | (3.1)% |
| Tax Provision (Benefit) - Continuing Ops: | $83 | (1.9)% | $98 | (5.6)% |

---

\| F-24 \| <br>

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

In connection with the retrospective adoption of ASU 2023-09, the following table presents the tax effects of significant temporary differences that give rise to the Company's net deferred tax assets and liabilities as of December 31, 2025 and 2024::

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** |
| Inventory of deferreds: | Current  | Long-term | Current | Long-term  |
| Deferred revenue  | $—  |  | $—  | 1 |
| Basis difference in intangible assets  | —  | 1656 | —  | 5473 |
| Inventory reserve and UNICAP  | —  | 1 | —  | 1040 |
| Net operating loss carryforwards  | —  | 22378 | —  | 7025 |
| Accumulated research and development credits  | —  | 126 | —  | 125 |
| Accrued liabilities  | —  | 33 | —  | 99 |
| Non-deductible ASC 718 compensation expense  | —  | 91 | —  | 167 |
| Allowance for sales returns and doubtful accounts  | —  | 75 | —  | 101 |
| Difference in property and equipment basis  |  | (20) |  | (94) |
| Convertible Debt |  | (71) |  | (110) |
| Business Interest Expense |  | 7 |  |  |
| Capitalized research expenditures |  | 375 |  | 1839 |
| Other  | —  | 295 | —  | 309 |
| &nbsp;&nbsp;&nbsp; Total net deferred income tax asset  | —  | 24946 | —  | 15975 |
| &nbsp;&nbsp;&nbsp; Less: Valuation allowance  |  | (24946) |  | (15975) |
| &nbsp;&nbsp;&nbsp; Net deferred income tax asset (liability)  | $— |  | $— |  |

---

**Taxes Paid by Jurisdiction (ASU 2023-09)** (in thousands):

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| U.S. Federal  | $81  | $76  |
| U.S. State | 4 | 22 |
| Foreign (India) | 18 | 0 |
| **Total taxes paid**  | $103  | $98  |

---

The Company has not provided for foreign withholding taxes on undistributed earnings of its non-U.S. subsidiaries since these earnings are intended to be reinvested indefinitely, in accordance with guidelines contained in ASC Topic 740, *Accounting for Income Taxes*. It is not practical to estimate the amount of additional taxes that might be payable on such undistributed earnings.

The Company routinely evaluates the likelihood of realizing the benefit of its deferred tax assets and may record a valuation allowance if, based on all available evidence, it determines that it is more likely than not some portion of the tax benefit will not be realized. As of December 31, 2025, the Company had an aggregate of approximately $24,947 in deferred tax assets primarily related to intangible assets, net operating losses, tax credit carryforwards, and inventory basis differences. On a quarterly basis, the Company tests the value of deferred tax assets for impairment at the taxpaying-component level within each tax jurisdiction. Significant judgment and estimates are required in determining whether valuation allowances should be established as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following:

● sufficient taxable income within the allowed carryback or carryforward periods; 

● future reversals of existing taxable temporary differences, including any tax planning strategies that could be utilized; 

● nature or character (e.g., ordinary vs. capital) of the deferred tax assets and liabilities; and 

● future taxable income exclusive of reversing temporary differences and carryforwards. 

Based on the foregoing criteria, the Company determined that it does not meet the "more likely than not" threshold that net operating losses, tax credits and other deferred tax assets will be realized. Accordingly, the Company recorded a full valuation allowance at December 31, 2025.

As of December 31, 2025 the Company has federal net operating loss ("NOL") carryforwards of approximately $74,344 (pre-tax), state NOL carryforwards of approximately $76,036 (pre-tax) and Spain NOL carryforwards of approximately $15,034 (pre-tax). The federal NOL carryforward expires in 2030. The Spain NOL carryforward does not expire. The state NOL carryforwards expire over various periods.

\| F-25 \| <br>

------

[**Table of Contents**](#TOC)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts)

Effective July 1, 2007, the Company adopted the accounting standards related to uncertain tax positions. This standard requires that tax positions be assessed using a two-step process. A tax position is recognized if it meets a "more likely than not" threshold, and is measured at the largest amount of benefit that is greater than 50 percent likely of being realized. Uncertain tax positions must be reviewed at each balance sheet date. Liabilities recorded as a result of this analysis must generally be recorded separately from any current or deferred income tax accounts.

The total amount of unrecognized tax benefits for continuing operations at December 31, 2025 and 2024, that would favorably impact our effective tax rate if recognized was $1,162 and $1,101, respectively. As of December 31, 2025 and 2024, we accrued $279 and $198, respectively, in interest and penalties related to unrecognized tax benefits. We account for interest expense and penalties for unrecognized tax benefits as part of our income tax provision.

Although we believe our estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such difference could have a material impact on our income tax provision and operating results in the period in which we make such determination.

A reconciliation of the beginning and ending amount of liabilities associated with uncertain tax positions is as follows:

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,**  | **Year ended December 31,**  |
|  | **2025** | **2024** |
| Balance - beginning of year  | $969  | $968  |
| &nbsp;&nbsp;&nbsp; Additions based on tax positions related to the current year  | 61 | 17  |
| &nbsp;&nbsp;&nbsp; Reductions for tax positions of prior years  |  | (8 ) |
| &nbsp;&nbsp;&nbsp; Lapse in statutes of limitations  |  | (8 ) |
| Uncertain tax positions, ending balance  | $1030  | $969  |

---

The Company's U.S. federal income tax returns for 2018 through 2025 are subject to examination. The Company's U.S. 2018 federal income tax return is currently under examination. The Company also files in various state and foreign jurisdictions. With few exceptions, the Company is no longer subject to federal, state, or non-U.S. income tax examinations by tax authorities for years prior to 2017.

**Note 15 - Capital Structure: Class A Redeemable Preferred Stock**

On July 18, 2025, following Board authorization on June 20, 2025, filing of the Certificate of Designation on June 24, 2025, and Nasdaq Corporate Data Operations approval on July 11, 2025 (the record date), the Company issued 2,069,065 shares of its Class A Redeemable Preferred Stock as a one-time special stock dividend (one Class A share for each common share and common stock equivalent outstanding as of the record date). 2,069,066 shares are authorized and 2,069,065 were issued and outstanding as of December 31, 2025.

Pursuant to the Certificate of Designation, the Class A shares are mandatorily redeemable upon an Asset Sale for 100% of the net proceeds as defined therein. The closing of the Asset Sale on October 24, 2025 (see Note 2) triggered this mandatory redemption obligation. As of December 31, 2025, the redemption had not yet been completed.

The Company currently estimates the final redemption amount will be approximately $50 after permitted expenses and net asset recoveries. Accordingly, the Class A Redeemable Preferred Stock has been reclassified from temporary equity to a current liability on the consolidated balance sheet as of December 31, 2025.

The Class A Redeemable Preferred Stock is a participating security only in the liquidation or sale proceeds and does not receive dividends other than the redemption amount. Therefore, it is excluded from the computation of diluted earnings per share as anti-dilutive for the periods presented.

The actual cash redemption payment is expected to occur after December 31, 2025 and is treated as a non-recognized subsequent event (see Note 17 – Subsequent Events).

---

| | | |
|:---|:---|:---|
| **Class A Redeemable Preferred**  |  |  |
| **(dollars in thousands, shares in whole amounts)**  | **Amount** | **Shares** |
| Beginning balance, July 1, 2025  | $— | $— |
| Issuance via special stock dividend, par value (July 18, 2025)  | 2 | 2069065 |
| Record temporary equity at estimated redemption value<br>| 756 |  |
| Reclassification to current liability upon Asset Sale closing (October 24, 2025) | (758) |  |
| Balance, December 31, 2025  | $— | $2069065 |
| Class A Redeemable Preferred Stock redemption payable (current liability, discontinued operations) | 50 | 2069065 |

---

\| F-26 \|

------

[**Table of Contents**](#TOC)

**Note 16 - Geographic Sales Information**

The following geographic sales information relates to the discontinued operations for the periods presented.

The United States was the only country to contribute more than 10 percent of total revenues in each fiscal year. The Company's revenues are substantially denominated in U.S. dollars and are summarized geographically as follows:

---

| | | |
|:---|:---|:---|
|  | **Year ended December 31,**  | **Year ended December 31,**  |
|  | **2025** | **2024** |
| United States  | $3328  | $3756  |
| All other countries  | 2681  | 7630  |
| Total  | $6009  | $11386  |

---

**Note 17 - Subsequent events**

Class A Redeemable Preferred Stock Redemption

Net proceeds from the October 2025 Asset Sale, after permitted expenses, are contractually required to be used to redeem all outstanding shares of the Company's Class A Redeemable Preferred Stock. As of the date these consolidated financial statements were issued, the redemption had not yet occurred. The exact net proceeds available for redemption could not be determined as of December 31, 2025 because permitted expenses were still being finalized. The Company currently estimates that the final net amount available for redemption will be approximately $50. The redemption is expected to occur after the issuance of these financial statements and will be recognized in the period in which it takes place. See Note 15 – Capital Structure for additional information regarding the Class A Redeemable Preferred Stock.

On January 1, 2026, Simon Brewer was rehired as Chief Financial Officer and Principal Financial Officer under a new employment agreement.

On January 2, 2026, Derek Graham was rehired as part-time Chief Executive Officer and Principal Executive Officer under a new employment agreement.

On January 9, 2026, the Company paid Simon Brewer a $75,000 sign-on bonus with no clawback or retention conditions.

The Company granted retention bonuses to Derek Graham and Simon Brewer contingent upon the completion of projects and the duration of employment, and the closing of a future transaction, respectively.

*Lease Terminations*

* On February 24, 2026, the Company entered into an Early Termination Agreement for the 2,590 square-foot warehouse facility in Salt Lake City, Utah (363 West 2720 South, Suite B). The lease terminated effective midnight February 28, 2026. The Company paid a buyout of $42,556.50 and forfeited its security deposit. The Company has no further liability under this lease.

* In March, 2026, the Company entered into a Settlement, Release and Agreement to Terminate Lease for the 1,350 square-foot facility in Gainesville, Florida (2610 NW 43rd Street, Suite 2-C). The Company paid $30,000 and forfeited its $2,236.50 security deposit in exchange for full termination of the lease and a mutual release of all obligations. The Company has no further liability under this lease.

On March 2, 2026, the Company entered into a Securities Purchase Agreement with First Finance Ltd. (its largest stockholder) and issued 437,500 shares of common stock at $4.00 per share and a warrant to purchase up to 437,500 additional shares at $5.00 per share for aggregate gross proceeds of $1,750. Of the proceeds, $500 became immediately available to the Company, and the remaining $1,250 will become available upon completion of the Company's reincorporation from Delaware to Nevada.

*Warrant Repurchase* 

On March 9, 2026, the Company entered into a Warrant Repurchase Agreement with CVI Investments, Inc. and repurchased certain outstanding common stock purchase warrants originally issued on September 12, 2021. The repurchased warrants were exercisable for an aggregate of 24,155 shares of the Company's common stock. The Company paid an aggregate cash purchase price of $22,000 ($0.9108 per underlying share). Upon settlement, the warrants were cancelled and are of no further force or effect.

*Nevada Reincorporation* 

On March 12, 2026, stockholders holding a majority of the voting power of the Company's outstanding capital stock entitled to vote and a majority of the outstanding shares of Class A Redeemable Preferred Stock approved, by written consent in lieu of a meeting, the reincorporation of the Company from the State of Delaware to the State of Nevada by conversion (the "Nevada Reincorporation"). The reincorporation is expected to become effective no earlier than twenty (20) calendar days after the mailing of the Information Statement on Schedule 14C to the Company's stockholders. This action satisfies the condition precedent in the March 2, 2026 Securities Purchase Agreement with First Finance Ltd. for the release of the remaining $1.25 million of proceeds from the $1.75 million private placement. See the Company's Current Report on Form 8-K filed March 17, 2026 for additional information.

\| F-27 \|

------

## Exhibit 3.7

**EXHIBIT 3.7**

****

<br> **CLEARONE, INC.**<br>(the "**Company**")<br>

**<u>RESOLUTIONS OF THE BOARD OF DIRECTORS</u>**

The undersigned, being all of directors of the Company, a Delaware corporation, by consent in writing pursuant to the authority contained in the corporate law of the State of Delaware, does hereby consent to the following actions of the Company, to be effective as of the 26th day of February, 2026.

**<u>AMENDMENT TO BYLAWS</u>**

**WHEREAS**, the Company's certificate of incorporation has been amended to eliminate the prohibition against stockholder action by written consent.

**WHEREAS**, the board of directors of the Company (the "**Board**") has determined that it is in the best interests of the Company and its stockholders to amend the Company's bylaws to eliminate the prohibition against stockholder action by written consent, too.

**NOW, THEREFORE, BE IT RESOLVED,** that Company's bylaws be amended by deleting in its entirety Article I, Section 1.11 and replacing it to read as follows:

"**Section 1.11. Action by Written Consent.** 

Any action required or permitted to be taken at any annual or special meeting of stockholders of the Corporation may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of outstanding stock of the Corporation having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the Corporation by delivery to its registered office in Delaware, its principal place of business, or to an officer or agent of the Corporation having custody of the book in which proceedings of meetings of stockholders are recorded."

**RESOLVED FURTHER,** that any and all acts, transactions, agreements or certificates previously signed on behalf of the Company by the officers of the Company (together, the "**Authorized Officers**" and each, an "**Authorized Officer**") consistent with the foregoing resolutions and in furtherance thereof be, and they hereby are, approved and ratified in all respects as the true acts and deeds of the Company with the same force and effect as if each such act, transaction, agreement or certificate had been specifically authorized in advance by resolution of the Board and that the Authorized Officer did execute the same.

**RESOLVED FURTHER,** that the Authorized Officers and all other officers be, and each of them hereby is, authorized, empowered and directed, for and on behalf of the Company and in its name, to take, or cause to be taken, any and all actions, to execute and deliver any and all agreements, certificates, assignments, instruments or other documents, and to do any and all things that, in the judgment of such officer or officers, may be necessary or advisable to effectuate the foregoing resolutions; such execution and delivery by any such officer or officers of any such agreement, certificate, assignment, instrument or other document or the doing by any of them of any such act (including the authorization of any change in any such agreement, certificate, assignment, instrument or other document) shall conclusively establish both the authority of such person so to do from the Company and the approval of the Board.

------

**IN WITNESS WHEREOF**, these resolutions may be executed in counterpart and such counterparts together shall constitute a single instrument. Delivery of an executed counterpart of these resolutions by electronic means, including by facsimile transmission or by electronic delivery in portable document format (".pdf"), shall be equally effective as delivery of a manually executed counterpart hereof. Notwithstanding the date of execution of these resolutions by the undersigned, these resolutions shall be deemed to be executed as of the date set forth above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **____________________________**<br>**ERIC L. ROBINSON**<br>| &nbsp;&nbsp; **____________________________**<br>**ERIC BOEHNKE** |
| &nbsp;&nbsp; **____________________________**<br>**LISA B. HIGLEY** | &nbsp;&nbsp;&nbsp;&nbsp; **____________________________**<br>**YOUNGSUN PARK**<br>|
| &nbsp;&nbsp; **____________________________**<br>**BRUCE WHALEY** | &nbsp;&nbsp; <br>|

---

------

## Exhibit 23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in Registration Statements (Nos. 333-205356, 333-209130, 333-148789 and 333-137859) on Form S-8 on Form S-1 (No. 333-249506) and on Form S-3 (Nos. 333-259799 and 333-238085) of ClearOne, Inc. of our report dated March 31, 2026, relating to our audit of the consolidated financial statements, which appears in this Annual Report on Form 10-K of ClearOne, Inc. for the year ended December 31, 2025.

/s/ Tanner LLP

Lehi, UT

March 31, 2026

## Exhibit 31.1

**EXHIBIT 31.1**

****

<br> **CERTIFICATION**

I, Derek L. Graham, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this annual report of ClearOne, Inc. on Form 10-K;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| March 31, 2026  | By:  | */s/ Derek L. Graham* |
|  |  | Derek L. Graham |
|  |  | Chief Executive Officer |
|  |  | (Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2** 

**CERTIFICATION**

I, Simon Brewer, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this annual report of ClearOne, Inc. on Form 10-K;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| March 31, 2026  | By:  | */s/ Simon Brewer* |
|  |  | Simon Brewer |
|  |  | Chief Financial Officer  |
|  |  | (Principal Accounting and Principal Financial Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**Pursuant to 18 U.S.C. Section 1350, As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

I, Derek Graham, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the annual report of ClearOne, Inc. (the "Company") on Form 10-K for the year ended December 31, 2025, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such annual report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| March 31, 2026  | By:  | */s/ Derek Graham* |
|  |  | Derek Graham  |
|  |  | Chief Executive Officer  |
|  |  | (Principal Executive Officer) |

---

This certification accompanies each Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**Pursuant to 18 U.S.C. Section 1350, As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

I, Simon Brewer, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the annual report of ClearOne, Inc. (the "Company") on Form 10-K for the year ended December 31, 2025 , fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such annual report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| March 31, 2026  | By:  | */s/ Simon Brewer* |
|  |  | Simon Brewer |
|  |  | Chief Financial Officer  |
|  |  | (Principal Accounting and Principal Financial Officer) |

---

This certification accompanies each Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 97.1

**EXHIBIT 97.1**

**CLEARONE, INC. ("the Company")**

**CLAWBACK POLICY** 

**<u>Introduction</u>**

The Board of Directors of the Company (the "**Board**") believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's pay-for-performance compensation philosophy. The Board has therefore adopted this policy which provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws (the "**Policy**"). This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934 (the "**Exchange Act**"), Rule 10D-1 promulgated thereunder, and Section 5608 of the Nasdaq Stock Market Rules.

**<u>Administration</u>**

This Policy shall be administered by the Board or, if so designated by the Board, the Compensation Committee, in which case references herein to the Board shall be deemed references to the Compensation Committee. Any determinations made by the Board shall be final and binding on all affected individuals.

**<u>Covered Executives</u>**

This Policy applies to the Company's current and former executive officers, as determined by the Board in accordance with Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, and the listing standards of the national securities exchange on which the Company's securities are listed, and such other senior executives/employees who may from time to time be deemed subject to the Policy by the Board ("**Covered Executives**").

**<u>Recoupment; Accounting Restatement</u>**

In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company's material noncompliance with any financial reporting requirement under the securities laws, the Board will require reimbursement or forfeiture of any excess Incentive Compensation received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company is required to prepare an accounting restatement.

**<u>Incentive Compensation</u>**

For purposes of this Policy, Incentive Compensation means any of the following; provided that, such compensation is granted, earned, or vested based wholly or in part on the attainment of a financial reporting measure:

* Annual bonuses and other short- and long-term cash incentives.

* Stock options.

* Stock appreciation rights.

* Restricted stock.

* Restricted stock units.

* Performance shares.

* Performance units.

* Deferred compensation plan units.

* Supplemental Executive Retirement Plan ("SERP") benefits.

* Long-term disability or life insurance benefits.<br>

* Financial reporting measures include:

* Company stock price.

* Total shareholder return.

------

* Revenues.

* Net income.

* Earnings before interest, taxes, depreciation, and amortization (EBITDA).

* Liquidity measures such as working capital or operating cash flow.

* Return measures such as return on invested capital or return on assets.

* Earnings measures such as earnings per share.

**<u>Excess Incentive Compensation: Amount Subject to Recovery</u>**

The amount to be recovered will be the excess of the Incentive Compensation paid to the Covered Executive based on the erroneous data over the Incentive Compensation that would have been paid to the Covered Executive had it been based on the restated results, as determined by the Board.

If the Board cannot determine the amount of excess Incentive Compensation received by the Covered Executive directly from the information in the accounting restatement, then it will make its determination based on a reasonable estimate of the effect of the accounting restatement.

**<u>Method of Recoupment</u>**

The Board will determine, in its sole discretion, the method for recouping Incentive Compensation hereunder which may include, without limitation:

(a) requiring reimbursement of cash Incentive Compensation previously paid;

(b) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;

(c) offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Executive;

(d)) cancelling outstanding vested or unvested equity awards; and/or

(e) taking any other remedial and recovery action permitted by law, as determined by the Board.

**<u>No Indemnification</u>**

The Company shall not indemnify any Covered Executives against the loss of any incorrectly awarded Incentive Compensation.

**<u>Interpretation</u>**

The Board is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder and any applicable rules or standards adopted by the Securities and Exchange Commission or any national securities exchange on which the Company's securities are listed.

**<u>Effective Date</u>**

This Policy shall be effective as of the date it is adopted by the Board (the "**Effective Date**") and shall apply to Incentive Compensation that is approved, awarded or granted to Covered Executives on or after that date.

**<u>Amendment; Termination</u>**

The Board may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to reflect future amendments to Rule 10D-1 and to comply with any new or amended rules or standards adopted by a national securities exchange on which the Company's securities are listed. The Board may terminate this Policy at any time.

**<u>Other Recoupment Rights</u>**

The Board intends that this Policy will be applied to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree to abide by the terms of this Policy. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.

**<u>Impracticability</u>**

The Board shall recover any excess Incentive Compensation in accordance with this Policy unless such recovery would be impracticable, as determined by the Board in accordance with Rule 10D-1 of the Exchange Act and the listing standards of the national securities exchange on which the Company's securities are listed.

**<u>Successors</u>**

This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.

<br>